Regulation	O
of	O
IL-4	B-protein
expression	O
by	O
the	O
transcription	B-protein
factor	I-protein
JunB	B-protein
during	O
T	O
helper	O
cell	O
differentiation	O
.	O

The	O
molecular	O
basis	O
for	O
restricted	O
cytokine	B-protein
expression	O
by	O
T	B-cell_type
helper	I-cell_type
1	I-cell_type
(	I-cell_type
Th1	I-cell_type
)	I-cell_type
and	I-cell_type
T	I-cell_type
helper	I-cell_type
2	I-cell_type
(	I-cell_type
Th2	I-cell_type
)	I-cell_type
cells	I-cell_type
is	O
unclear	O
.	O

Previous	O
studies	O
found	O
that	O
P1	B-DNA
,	O
an	O
element	O
of	O
the	O
interleukin	B-DNA
4	I-DNA
(	I-DNA
IL-4	I-DNA
)	I-DNA
promoter	I-DNA
that	O
binds	O
AP-1	O
,	O
is	O
important	O
for	O
Th2-restricted	O
IL-4	B-protein
expression	O
.	O

Here	O
we	O
show	O
that	O
JunB	B-protein
,	O
but	O
not	O
the	O
other	O
Jun	B-protein
family	I-protein
members	I-protein
,	O
was	O
selectively	O
induced	O
in	O
Th2	B-cell_type
cells	I-cell_type
and	O
not	O
in	O
Th1	B-cell_type
cells	I-cell_type
during	O
differentiation	O
.	O

JunB	B-protein
has	O
previously	O
been	O
considered	O
to	O
be	O
a	O
negative	O
regulator	O
of	O
transcription	O
.	O

However	O
,	O
we	O
show	O
that	O
JunB	B-protein
binds	O
directly	O
to	O
the	O
P1	B-DNA
site	I-DNA
and	O
synergizes	O
with	O
c-Maf	B-protein
to	O
activate	O
an	O
IL-4	B-DNA
luciferase	I-DNA
reporter	I-DNA
gene	I-DNA
.	O

JunB	B-protein
-control	O
of	O
IL-4	B-protein
expression	O
is	O
mediated	O
by	O
the	O
phosphorylation	O
of	O
JunB	B-protein
at	O
Thr102	O
and-	O
104	O
by	O
JNK	B-protein
MAP	I-protein
kinase	I-protein
.	O

The	O
synergy	O
between	O
c-Maf	B-protein
and	O
JunB	B-protein
can	O
be	O
attributed	O
to	O
cooperative	O
DNA	O
binding	O
,	O
which	O
is	O
facilitated	O
by	O
JunB	B-protein
phosphorylation	O
.	O

In	O
transgenic	O
mice	O
,	O
elevated	O
JunB	B-protein
levels	O
caused	O
increased	O
expression	O
of	O
several	O
Th2	B-protein
cytokines	I-protein
in	O
developing	O
Th1	B-cell_type
cells	I-cell_type
.	O

JunB	B-protein
also	O
upregulated	O
IL-4	B-protein
expression	O
in	O
response	O
to	O
immunization	O
.	O

Thus	O
,	O
the	O
early	O
increase	O
of	O
JunB	B-protein
protein	O
in	O
Th2	B-cell_type
cells	I-cell_type
can	O
provide	O
the	O
specificity	O
for	O
c-Maf	B-protein
in	O
IL-4	B-protein
expression	O
during	O
T	O
cell	O
development	O
and	O
directs	O
thereby	O
Th2	O
differentiation	O
.	O

The	NULL
EMBO	NULL
Journal	NULL
Vol.18	NULL
No.2	NULL
pp.420-432	NULL
,	NULL
1999	NULL
Regulation	NULL
of	NULL
IL-4	NULL
expression	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
JunB	NULL
during	NULL
T	NULL
helper	NULL
cell	NULL
differentiation	NULL
Baiyong	NULL
Li	NULL
,	NULL
Cathy	NULL
Tournier	NULL
'	NULL
,	NULL
Roger	NULL
J.Davis	NULL
'	NULL
and	NULL
Richard	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Section	NULL
of	NULL
Immunobiology	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
CT	NULL
06520	NULL
and	NULL
'Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Program	NULL
in	NULL
Molecular	NULL
Medicine	NULL
,	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Massachusetts	NULL
Medical	NULL
School	NULL
,	NULL
Worcester	NULL
,	NULL
MA	NULL
01605	NULL
,	NULL
USA	NULL
Corresponding	NULL
author	NULL
e-mail	NULL
:	NULL
richard	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
restricted	NULL
cytokine	NULL
expression	NULL
by	NULL
T	NULL
helper	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
and	NULL
T	NULL
helper	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cells	NULL
is	NULL
unclear	NULL
.	NULL

Previous	NULL
studies	NULL
found	NULL
that	NULL
P1	NULL
,	NULL
an	NULL
element	NULL
of	NULL
the	NULL
interleukin	NULL
4	NULL
(	NULL
IL-4	NULL
)	NULL
promoter	NULL
that	NULL
binds	NULL
AP-1	NULL
,	NULL
is	NULL
important	NULL
for	NULL
Th2-restricted	NULL
IL-4	NULL
expression	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
JunB	NULL
,	NULL
but	NULL
not	NULL
the	NULL
other	NULL
Jun	NULL
family	NULL
members	NULL
,	NULL
was	NULL
selectively	NULL
induced	NULL
in	NULL
Th2	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
Thl	NULL
cells	NULL
during	NULL
differentiation	NULL
.	NULL

JunB	NULL
has	NULL
previously	NULL
been	NULL
considered	NULL
to	NULL
be	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
we	NULL
show	NULL
that	NULL
JunB	NULL
binds	NULL
directly	NULL
to	NULL
the	NULL
P1	NULL
site	NULL
and	NULL
synergizes	NULL
with	NULL
c-Maf	NULL
to	NULL
activate	NULL
an	NULL
IL-4	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

JunB-control	NULL
of	NULL
IL-4	NULL
expression	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
JunB	NULL
at	NULL
Thr102	NULL
and	NULL
-104	NULL
by	NULL
JNK	NULL
MAP	NULL
kinase	NULL
.	NULL

The	NULL
synergy	NULL
between	NULL
c-Maf	NULL
and	NULL
JunB	NULL
can	NULL
be	NULL
attributed	NULL
to	NULL
cooperative	NULL
DNA	NULL
binding	NULL
,	NULL
which	NULL
is	NULL
facilitated	NULL
by	NULL
JunB	NULL
phosphorylation	NULL
.	NULL

In	NULL
transgenic	NULL
mice	NULL
,	NULL
elevated	NULL
JunB	NULL
levels	NULL
caused	NULL
increased	NULL
expression	NULL
of	NULL
several	NULL
Th2	NULL
cytokines	NULL
in	NULL
developing	NULL
Th1	NULL
cells	NULL
.	NULL

JunB	NULL
also	NULL
upregulated	NULL
IL-4	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
immunization	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
early	NULL
increase	NULL
of	NULL
JunB	NULL
protein	NULL
in	NULL
Th2	NULL
cells	NULL
can	NULL
provide	NULL
the	NULL
specificity	NULL
for	NULL
c-Maf	NULL
in	NULL
IL-4	NULL
expression	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
directs	NULL
thereby	NULL
Th2	NULL
differentiation	NULL
.	NULL

Keywords	NULL
:	NULL
cytokine/JunB/phosphorylation/Th2	NULL
Introduction	NULL
In	NULL
response	NULL
to	NULL
antigen	NULL
stimulation	NULL
,	NULL
naive	NULL
T	NULL
helper	NULL
(	NULL
Th	NULL
)	NULL
cells	NULL
differentiate	NULL
into	NULL
different	NULL
types	NULL
of	NULL
effector	NULL
cells	NULL
that	NULL
are	NULL
classified	NULL
based	NULL
on	NULL
their	NULL
distinct	NULL
cytokine	NULL
profiles	NULL
and	NULL
immune	NULL
regulatory	NULL
functions	NULL
(	NULL
Mosmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Paul	NULL
and	NULL
Seder	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Th1	NULL
cells	NULL
produce	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
interferon	NULL
y	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
and	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
cell-mediated	NULL
immune	NULL
response	NULL
against	NULL
intracellular	NULL
pathogens	NULL
.	NULL

Th2	NULL
cells	NULL
produce	NULL
IL-4	NULL
,	NULL
IL-5	NULL
and	NULL
IL-10	NULL
,	NULL
and	NULL
are	NULL
involved	NULL
in	NULL
humoral	NULL
immunity	NULL
and	NULL
the	NULL
allergic	NULL
response	NULL
.	NULL

There	NULL
is	NULL
ample	NULL
evidence	NULL
that	NULL
the	NULL
dominance	NULL
of	NULL
either	NULL
Th1	NULL
or	NULL
Th2	NULL
responses	NULL
directly	NULL
affects	NULL
the	NULL
outcome	NULL
of	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
immunologically	NULL
mediated	NULL
clinical	NULL
conditions	NULL
,	NULL
including	NULL
autoimmune	NULL
and	NULL
allergic	NULL
responses	NULL
,	NULL
and	NULL
infectious	NULL
diseases	NULL
(	NULL
Abbas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Romagnani	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
of	NULL
great	NULL
clinical	NULL
significance	NULL
to	NULL
420	NULL
identify	NULL
and	NULL
manipulate	NULL
factors	NULL
that	NULL
dictate	NULL
the	NULL
ratio	NULL
of	NULL
Th1	NULL
to	NULL
Th2	NULL
cells	NULL
.	NULL

The	NULL
course	NULL
of	NULL
CD4	NULL
T	NULL
cell	NULL
differentiation	NULL
appears	NULL
to	NULL
be	NULL
influenced	NULL
by	NULL
many	NULL
factors	NULL
.	NULL

Cytokines	NULL
are	NULL
critical	NULL
for	NULL
the	NULL
determination	NULL
of	NULL
the	NULL
outcome	NULL
of	NULL
the	NULL
differentiation	NULL
to	NULL
effector	NULL
T	NULL
cells	NULL
(	NULL
Paul	NULL
and	NULL
Seder	NULL
,	NULL
1994	NULL
;	NULL
Constant	NULL
and	NULL
Bottomly	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-4	NULL
that	NULL
is	NULL
present	NULL
during	NULL
priming	NULL
promotes	NULL
the	NULL
differentiation	NULL
of	NULL
Th2	NULL
cells	NULL
while	NULL
preventing	NULL
the	NULL
differentiation	NULL
of	NULL
Th1	NULL
cells	NULL
(	NULL
Hsieh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Seder	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Swain	NULL
,	NULL
1993	NULL
)	NULL
,	NULL
whereas	NULL
IL-12	NULL
and	NULL
IFN-y	NULL
have	NULL
the	NULL
opposite	NULL
effect	NULL
(	NULL
Hsieh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Manetti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Seder	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
T	NULL
helper	NULL
cell	NULL
subset	NULL
differentiation	NULL
is	NULL
still	NULL
unclear	NULL
.	NULL

The	NULL
well-established	NULL
role	NULL
of	NULL
IL-4	NULL
in	NULL
determining	NULL
Th2	NULL
differentiation	NULL
argues	NULL
that	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
IL-4	NULL
during	NULL
Th	NULL
differentiation	NULL
could	NULL
determine	NULL
the	NULL
outcome	NULL
.	NULL

Several	NULL
regulatory	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
within	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
which	NULL
are	NULL
capable	NULL
of	NULL
directing	NULL
expression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
transient	NULL
transfection	NULL
studies	NULL
(	NULL
Abe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Li-Weber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Bruhn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Chuypilo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Todd	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

These	NULL
sites	NULL
,	NULL
designated	NULL
PO	NULL
,	NULL
P1	NULL
,	NULL
P2	NULL
and	NULL
P3	NULL
,	NULL
contain	NULL
sequences	NULL
that	NULL
bind	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

P1	NULL
,	NULL
P2	NULL
and	NULL
P3	NULL
also	NULL
contain	NULL
adjacent	NULL
sites	NULL
that	NULL
bind	NULL
activator	NULL
protein	NULL
1	NULL
(	NULL
AP-1	NULL
)	NULL
(	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
cis-elements	NULL
demonstrated	NULL
that	NULL
both	NULL
the	NULL
PO	NULL
and	NULL
P1	NULL
regions	NULL
are	NULL
important	NULL
in	NULL
determining	NULL
Th2-specific	NULL
expression	NULL
of	NULL
IL-4	NULL
.	NULL

A	NULL
region	NULL
encompassing	NULL
PO	NULL
was	NULL
shown	NULL
to	NULL
confer	NULL
preferential	NULL
expression	NULL
in	NULL
long-term	NULL
cultured	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
(	NULL
Bruhn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
an	NULL
NFAT	NULL
site	NULL
and	NULL
to	NULL
its	NULL
proximal	NULL
side	NULL
,	NULL
a	NULL
MARE	NULL
half	NULL
site	NULL
which	NULL
was	NULL
shown	NULL
to	NULL
have	NULL
binding	NULL
affinity	NULL
for	NULL
both	NULL
C/EBPRB	NULL
and	NULL
c-Maf	NULL
(	NULL
Davydov	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

NFAT	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
IL-4	NULL
gene	NULL
activation	NULL
(	NULL
Chuvpilo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
present	NULL
in	NULL
both	NULL
Thl	NULL
and	NULL
Th2	NULL
cells	NULL
and	NULL
activates	NULL
the	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
characteristic	NULL
for	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
c-Maf	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
GATA-3	NULL
(	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
were	NULL
recently	NULL
reported	NULL
to	NULL
be	NULL
selectively	NULL
expressed	NULL
in	NULL
Th2	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
and	NULL
both	NULL
are	NULL
able	NULL
to	NULL
drive	NULL
ectopic	NULL
IL-4	NULL
expression	NULL
.	NULL

c-Maf	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
region	NULL
proximal	NULL
to	NULL
PO	NULL
and	NULL
activate	NULL
IL-4	NULL
transcription	NULL
synergistically	NULL
with	NULL
NFATp	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
transgenic	NULL
mouse	NULL
studies	NULL
,	NULL
a	NULL
multimerized	NULL
P1	NULL
region	NULL
(	NULL
AP-1	NULL
plus	NULL
NFAT	NULL
)	NULL
conferred	NULL
Th2-restricted	NULL
expression	NULL
of	NULL
transcriptional	NULL
activity	NULL
during	NULL
T	NULL
cell	NULL
differentiation	NULL
(	NULL
Wenner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
a	NULL
related	NULL
study	NULL
,	NULL
multimerization	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
P1	NULL
element	NULL
without	NULL
the	NULL
AP-1	NULL
site	NULL
was	NULL
expressed	NULL
in	NULL
both	NULL
Th1	NULL
and	NULL
Th2	NULL
subsets	NULL
(	NULL
Aune	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
Th2-specific	NULL
regulation	NULL
of	NULL
the	NULL
P1	NULL
element	NULL
may	NULL
result	NULL
from	NULL
regulation	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
AP-1	NULL
portion	NULL
of	NULL
the	NULL
element	NULL
.	NULL

©	NULL
European	NULL
Molecular	NULL
Biology	NULL
Organization	NULL
Our	NULL
recent	NULL
examination	NULL
of	NULL
AP-1	NULL
activity	NULL
during	NULL
T	NULL
helper	NULL
cell	NULL
differentiation	NULL
using	NULL
AP-1	NULL
luciferase	NULL
transgenic	NULL
mice	NULL
showed	NULL
that	NULL
a	NULL
high	NULL
level	NULL
of	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
was	NULL
induced	NULL
upon	NULL
stimulation	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
(	NULL
Rincon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

This	NULL
AP-1	NULL
activity	NULL
correlated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
JunB	NULL
,	NULL
which	NULL
accumulates	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
or	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
a	NULL
potential	NULL
role	NULL
for	NULL
JunB	NULL
in	NULL
Th2	NULL
differentiation	NULL
(	NULL
Rincon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
therefore	NULL
examined	NULL
whether	NULL
JunB	NULL
has	NULL
any	NULL
direct	NULL
effect	NULL
on	NULL
IL-4	NULL
expression	NULL
using	NULL
both	NULL
transient	NULL
transfection	NULL
and	NULL
transgenic	NULL
approaches	NULL
.	NULL

Early	NULL
transfection	NULL
studies	NULL
showed	NULL
that	NULL
JunB	NULL
inhibits	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
(	NULL
Chiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Schutte	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
and	NULL
later	NULL
findings	NULL
that	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
JunB	NULL
possesses	NULL
a	NULL
docking	NULL
site	NULL
but	NULL
not	NULL
phosphorylation	NULL
sites	NULL
for	NULL
JNK	NULL
(	NULL
Gupta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Kallunki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
both	NULL
pointed	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
JunB	NULL
is	NULL
a	NULL
repressor	NULL
of	NULL
transcription	NULL
mediated	NULL
by	NULL
AP-1	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
,	NULL
however	NULL
,	NULL
that	NULL
JunB	NULL
is	NULL
instead	NULL
a	NULL
strong	NULL
transcriptional	NULL
activator	NULL
of	NULL
IL-4	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
JunB	NULL
upregulates	NULL
Th2	NULL
cytokines	NULL
in	NULL
transgenic	NULL
mice	NULL
and	NULL
that	NULL
JunB	NULL
synergizes	NULL
with	NULL
c-Maf	NULL
to	NULL
activate	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

JunB	NULL
transcriptional	NULL
activity	NULL
,	NULL
as	NULL
well	NULL
as	NULL
its	NULL
synergism	NULL
with	NULL
c-Maf	NULL
for	NULL
IL-4	NULL
expression	NULL
,	NULL
is	NULL
enhanced	NULL
by	NULL
phosphorylation	NULL
on	NULL
Thr1l02	NULL
and	NULL
Thr1l04	NULL
by	NULL
JNK	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
a	NULL
new	NULL
molecular	NULL
mechanism	NULL
whereby	NULL
precursor	NULL
cells	NULL
differentiate	NULL
into	NULL
effector	NULL
cells	NULL
secreting	NULL
high	NULL
levels	NULL
of	NULL
Th2	NULL
cytokines	NULL
.	NULL

Results	NULL
Preferential	NULL
expression	NULL
of	NULL
JunB	NULL
protein	NULL
in	NULL
Th2	NULL
cells	NULL
Our	NULL
previous	NULL
study	NULL
demonstrated	NULL
that	NULL
among	NULL
the	NULL
Jun	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
AP-1	NULL
DNA-binding	NULL
complexes	NULL
containing	NULL
JunB	NULL
preferentially	NULL
accumulated	NULL
in	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Thl	NULL
cells	NULL
(	NULL
Rincon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

We	NULL
considered	NULL
it	NULL
to	NULL
be	NULL
likely	NULL
that	NULL
JunB	NULL
accumulation	NULL
would	NULL
account	NULL
for	NULL
the	NULL
enhanced	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
JunB	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
extracts	NULL
from	NULL
in	NULL
vitro	NULL
differentiated	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

At	NULL
day	NULL
3	NULL
of	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
purified	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
JunB	NULL
protein	NULL
level	NULL
was	NULL
upregulated	NULL
in	NULL
Th2	NULL
cells	NULL
relative	NULL
to	NULL
Th1	NULL
cells	NULL
,	NULL
while	NULL
c-Jun	NULL
and	NULL
JunD	NULL
protein	NULL
levels	NULL
were	NULL
approximately	NULL
the	NULL
same	NULL
in	NULL
Thl	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

We	NULL
further	NULL
investigated	NULL
the	NULL
kinetics	NULL
of	NULL
JunB	NULL
protein	NULL
expression	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
Th	NULL
precursors	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

While	NULL
the	NULL
level	NULL
of	NULL
JunB	NULL
protein	NULL
remained	NULL
relatively	NULL
constant	NULL
in	NULL
developing	NULL
Th1	NULL
cells	NULL
,	NULL
the	NULL
JunB	NULL
protein	NULL
level	NULL
was	NULL
upregulated	NULL
in	NULL
developing	NULL
Th2	NULL
cells	NULL
at	NULL
day	NULL
3	NULL
of	NULL
in	NULL
vitro	NULL
priming	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
by	NULL
JunB	NULL
The	NULL
upregulation	NULL
of	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
and	NULL
accumulation	NULL
of	NULL
JunB	NULL
in	NULL
Th2	NULL
cells	NULL
suggested	NULL
that	NULL
Th2-specific	NULL
AP-1	NULL
activity	NULL
is	NULL
contributed	NULL
by	NULL
JunB	NULL
.	NULL

The	NULL
P1	NULL
site	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
confer	NULL
Th2-restricted	NULL
IL-4	NULL
expression	NULL
,	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
AP-1	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
JunB	NULL
in	NULL
tissue-specific	NULL
expression	NULL
of	NULL
IL-4	NULL
.	NULL

We	NULL
therefore	NULL
tested	NULL
whether	NULL
JunB	NULL
could	NULL
drive	NULL
ectopic	NULL
expression	NULL
by	NULL
the	NULL
IL-4	NULL
promoter	NULL
in	NULL
the	NULL
B	NULL
lymphoma	NULL
cell	NULL
line	NULL
M12	NULL
,	NULL
which	NULL
does	NULL
not	NULL
usually	NULL
express	NULL
IL-4	NULL
.	NULL

JunB	NULL
regulates	NULL
Th2	NULL
differentiation	NULL
A	NULL
Thi	NULL
Tha	NULL
c-Jun	NULL
a	NULL
.	NULL

“	NULL
JunD	NULL
__	NULL
#	NULL
#	NULL
tat	NULL
w*	NULL
t-	NULL
»	NULL
JunB	NULL
gr	NULL
B	NULL
Day1	NULL
Day2	NULL
Day3	NULL
Th	NULL
10	NULL
2	NULL
1	NULL
2	NULL
1	NULL
2	NULL
JunB	NULL
|	NULL
sew	NULL
sow	NULL
woe	NULL
=-	NULL
»	NULL
deb	NULL
Actin	NULL
--	NULL
«	NULL
tik	NULL
aas	NULL
4b	NULL
#	NULL
i	NULL
ams	NULL
«	NULL
ih	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Upregulation	NULL
of	NULL
JunB	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
JunB	NULL
is	NULL
selectively	NULL
upregulated	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
were	NULL
differentiated	NULL
into	NULL
Th1	NULL
and	NULL
Th2	NULL
for	NULL
3	NULL
days	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
c-Jun	NULL
,	NULL
JunB	NULL
and	NULL
JunD	NULL
was	NULL
examined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
each	NULL
transcription	NULL
factor	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Time	NULL
course	NULL
of	NULL
JunB	NULL
protein	NULL
expression	NULL
during	NULL
Th1/Th2	NULL
differentiation	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
were	NULL
differentiated	NULL
towards	NULL
the	NULL
Th1	NULL
or	NULL
Th2	NULL
pathways	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
each	NULL
population	NULL
at	NULL
various	NULL
days	NULL
as	NULL
indicated	NULL
.	NULL

JunB	NULL
was	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

A	NULL
polyclonal	NULL
antibody	NULL
against	NULL
actin	NULL
was	NULL
used	NULL
as	NULL
a	NULL
loading	NULL
control	NULL
for	NULL
immunoblots	NULL
.	NULL

The	NULL
full-length	NULL
cDNA	NULL
of	NULL
JunB	NULL
or	NULL
other	NULL
Jun	NULL
family	NULL
members	NULL
were	NULL
co-transfected	NULL
with	NULL
an	NULL
IL-4	NULL
promoter	NULL
(	NULL
-157	NULL
to	NULL
+68	NULL
)	NULL
reporter	NULL
plasmid	NULL
into	NULL
M12	NULL
cells	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
generated	NULL
with	NULL
or	NULL
without	NULL
PMA/ionomycin	NULL
stimulation	NULL
was	NULL
measured	NULL
.	NULL

A	NULL
LacZ	NULL
gene	NULL
was	NULL
also	NULL
co-transfected	NULL
and	NULL
the	NULL
B-galactosidase	NULL
(	NULL
-gal	NULL
)	NULL
activity	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
to	NULL
normalize	NULL
the	NULL
luciferase	NULL
reading	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Overall	NULL
,	NULL
c-Jun	NULL
and	NULL
JunB	NULL
exhibited	NULL
a	NULL
similar	NULL
ability	NULL
,	NULL
which	NULL
was	NULL
much	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
JunD	NULL
,	NULL
to	NULL
activate	NULL
ectopic	NULL
expression	NULL
of	NULL
the	NULL
IL-4	NULL
reporter	NULL
gene	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
for	NULL
both	NULL
JunB	NULL
and	NULL
c-Jun	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
responded	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
in	NULL
a	NULL
range	NULL
from	NULL
2-10	NULL
ug	NULL
of	NULL
input	NULL
DNA	NULL
yielding	NULL
a	NULL
10-fold	NULL
increase	NULL
after	NULL
PMA/ionomycin	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
dramatic	NULL
increase	NULL
in	NULL
IL-4	NULL
promoter	NULL
activity	NULL
was	NULL
observed	NULL
when	NULL
as	NULL
much	NULL
as	NULL
10	NULL
ug	NULL
JunD	NULL
expression	NULL
vector	NULL
was	NULL
co-transfected	NULL
.	NULL

Since	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
c-Jun	NULL
is	NULL
known	NULL
to	NULL
be	NULL
enhanced	NULL
by	NULL
phosphorylation	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAP	NULL
kinases	NULL
)	NULL
(	NULL
Whitmarsh	NULL
and	NULL
Davis	NULL
,	NULL
1996	NULL
)	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
high	NULL
level	NULL
of	NULL
transcriptional	NULL
activity	NULL
that	NULL
was	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
PMA/ionomycin	NULL
was	NULL
mediated	NULL
by	NULL
MAP	NULL
kinase	NULL
signaling	NULL
pathways	NULL
.	NULL

At	NULL
least	NULL
three	NULL
distinct	NULL
MAP	NULL
kinase	NULL
families	NULL
have	NULL
been	NULL
identified	NULL
:	NULL
ERK	NULL
(	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
)	NULL
,	NULL
JNK	NULL
(	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
or	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
,	NULL
SAPK	NULL
)	NULL
and	NULL
p38	NULL
MAP	NULL
kinase	NULL
(	NULL
also	NULL
known	NULL
as	NULL
cytokine-suppressive	NULL
-	NULL
anti-inflammatory	NULL
-	NULL
drug-binding	NULL
protein	NULL
,	NULL
CSBP	NULL
,	NULL
or	NULL
reactivating	NULL
kinase	NULL
,	NULL
RK	NULL
)	NULL
.	NULL

ERK	NULL
is	NULL
mainly	NULL
involved	NULL
in	NULL
responses	NULL
to	NULL
signals	NULL
initiated	NULL
by	NULL
growth	NULL
factors	NULL
and	NULL
hormones	NULL
(	NULL
Robinson	NULL
and	NULL
Cobb	NULL
,	NULL
1997	NULL
)	NULL
,	NULL
whereas	NULL
JNK	NULL
and	NULL
p38	NULL
MAP	NULL
kinase	NULL
are	NULL
activated	NULL
by	NULL
environmental	NULL
stresses	NULL
and	NULL
pro-inflammatory	NULL
cytokines	NULL
(	NULL
Ip	NULL
and	NULL
Davis	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
the	NULL
possible	NULL
role	NULL
of	NULL
MAP	NULL
kinases	NULL
in	NULL
IL-4	NULL
expression	NULL
,	NULL
we	NULL
first	NULL
examined	NULL
MAP	NULL
kinase	NULL
activation	NULL
in	NULL
M12	NULL
cells	NULL
after	NULL
PMA/ionomycin	NULL
treatment	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

421	NULL
B.Li	NULL
et	NULL
al	NULL
.	NULL

A	NULL
B	NULL
control	NULL
UNO	NULL
-	NULL
PMA/ION	NULL
JNK	NULL
p3SMAPK	NULL
k	NULL
p	NULL
EHPMA/	NULL
ION	NULL
=	NULL
3	NULL
3	NULL
3	NULL
O	NULL
305	NULL
5	NULL
£	NULL
0	NULL
E	NULL
0	NULL
€	NULL
0	NULL
<	NULL
3	NULL
2	NULL
.	NULL

>	NULL
2	NULL
4	NULL
10	NULL
O	NULL
2	NULL
0	NULL
2	NULL
0	NULL
2	NULL
5	NULL
a	NULL
0	NULL
w	NULL
0	NULL
o	NULL
0	NULL
0	NULL
d	NULL
0	NULL
@	NULL
#	NULL
2	NULL
>	NULL
>	NULL
>	NULL
Fo	NULL
E4	NULL
s	NULL
=	NULL
e	NULL
6	NULL
H	NULL
3	NULL
q	NULL
§	NULL
4	NULL
£	NULL
[	NULL
3	NULL
]	NULL
6	NULL
o	NULL
t	NULL
o	NULL
$	NULL
1°	NULL
0	NULL
o	NULL
o	NULL
a	NULL
>	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
5	NULL
a	NULL
Time	NULL
Time	NULL
Time	NULL
a	NULL
3	NULL
10	NULL
0	NULL
-	NULL
10000	NULL
20000	NULL
30000	NULL
c-Jun	NULL
--	NULL
*	NULL
,	NULL
ATF2	NULL
ﬂ-	NULL
“	NULL
..	NULL
c-Myc	NULL
wes	NULL
Luciferase/lacZ	NULL
Time	NULL
_	NULL
0	NULL
5	NULL
15	NULL
3060120	NULL
0	NULL
5	NULL
1530	NULL
60120	NULL
0	NULL
5	NULL
15	NULL
30	NULL
60120	NULL
C	NULL
D	NULL
Control	NULL
SNO	NULL
PMA¥/ON	NULL
EPMA/ION	NULL
JIP	NULL
JunB	NULL
JIP+JunB	NULL
c-Jun	NULL
IL-4	NULL
luciferase	NULL
JIP+c-Jun	NULL
0	NULL
2000	NULL
4000	NULL
6000	NULL
8000	NULL
Luciferase/LacZ	NULL
c-Jun	NULL
Api	NULL
luciferase	NULL
Luciferase	NULL
collagenase	NULL
Api	NULL
JunB+MLK3	NULL
c-	NULL
Jun+	NULL
MLK3	NULL
JunB+	NULL
MLK3	NULL
c-	NULL
Jun+	NULL
MLK3	NULL
JunB+MLK3	NULL
c-Jun+	NULL
MLK3	NULL
Control	NULL
MLK3	NULL
JunB	NULL
c-	NULL
Jun	NULL
Control	NULL
MLK3	NULL
JunB	NULL
c-	NULL
Jun	NULL
Control	NULL
MLK3	NULL
JunB	NULL
c-	NULL
Jun	NULL
0	NULL
5000	NULL
10000	NULL
15000	NULL
20000	NULL
25000	NULL
30000	NULL
Luciferase/	NULL
LacZ	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
by	NULL
JunB	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Transactivation	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
by	NULL
c-Jun	NULL
,	NULL
JunB	NULL
and	NULL
JunD	NULL
.	NULL

Various	NULL
amounts	NULL
of	NULL
expression	NULL
vector	NULL
for	NULL
Jun	NULL
family	NULL
members	NULL
were	NULL
co-transfected	NULL
with	NULL
4	NULL
ug	NULL
IL-4	NULL
promoter	NULL
luciferase	NULL
and	NULL
50	NULL
ng	NULL
B-gal	NULL
vectors	NULL
into	NULL
M12	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
overnight	NULL
and	NULL
then	NULL
treated	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
or	NULL
not	NULL
treated	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

Extracts	NULL
were	NULL
made	NULL
24	NULL
h	NULL
later	NULL
and	NULL
relative	NULL
activities	NULL
of	NULL
luciferase	NULL
over	NULL
LacZ	NULL
were	NULL
determined	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PMA/ionomycin	NULL
stimulates	NULL
JNK	NULL
activity	NULL
in	NULL
M12	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
various	NULL
times	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

Endogenous	NULL
JNK	NULL
,	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
ERK	NULL
were	NULL
immunoprecipitated	NULL
and	NULL
the	NULL
MAPK	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
immune	NULL
complex	NULL
by	NULL
protein	NULL
kinase	NULL
assay	NULL
using	NULL
recombinant	NULL
c-Jun	NULL
,	NULL
ATF2	NULL
and	NULL
c-Myc	NULL
as	NULL
substrate	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
phosphorylated	NULL
c-Jun	NULL
,	NULL
ATF2	NULL
and	NULL
c-Myc	NULL
were	NULL
detected	NULL
after	NULL
SDS-PAGE	NULL
by	NULL
autoradiography	NULL
and	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

MAPK	NULL
activity	NULL
is	NULL
presented	NULL
as	NULL
relative	NULL
protein	NULL
kinase	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
)	NULL
JIP-1	NULL
blocks	NULL
the	NULL
induction	NULL
of	NULL
IL-4	NULL
luciferase	NULL
expression	NULL
in	NULL
M12	NULL
cells	NULL
.	NULL

M12	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
c-Jun	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
or	NULL
JunB	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
,	NULL
IL-4	NULL
luciferase	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
and	NULL
B-gal	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
vectors	NULL
with	NULL
or	NULL
without	NULL
JIP-1	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
left	NULL
overnight	NULL
and	NULL
then	NULL
treated	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
or	NULL
not	NULL
treated	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
with	NULL
PMA/ionomycin	NULL
.	NULL

Relative	NULL
activities	NULL
of	NULL
luciferase	NULL
over	NULL
LacZ	NULL
were	NULL
determined	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Transcriptional	NULL
activation	NULL
by	NULL
JunB	NULL
is	NULL
promoter	NULL
specific	NULL
.	NULL

Four	NULL
micrograms	NULL
of	NULL
IL-4	NULL
luciferase	NULL
,	NULL
c-Jun	NULL
AP-1	NULL
luciferase	NULL
or	NULL
collagenase	NULL
AP-1	NULL
luciferase	NULL
construct	NULL
and	NULL
50	NULL
ng	NULL
B-gal	NULL
vectors	NULL
were	NULL
co-transfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
expression	NULL
vector	NULL
for	NULL
JunB	NULL
,	NULL
c-Jun	NULL
or	NULL
MLK3	NULL
,	NULL
or	NULL
various	NULL
combinations	NULL
as	NULL
indicated	NULL
into	NULL
M12	NULL
cells	NULL
.	NULL

No	NULL
PMA/ionomycin	NULL
was	NULL
added	NULL
.	NULL

Extracts	NULL
were	NULL
made	NULL
24	NULL
h	NULL
later	NULL
and	NULL
relative	NULL
activities	NULL
of	NULL
luciferase	NULL
over	NULL
LacZ	NULL
were	NULL
determined	NULL
.	NULL

The	NULL
endogenous	NULL
JNK	NULL
,	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
ERK	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
immune	NULL
complex	NULL
protein	NULL
kinase	NULL
assay	NULL
using	NULL
c-Jun	NULL
,	NULL
ATF2	NULL
and	NULL
c-Myc	NULL
as	NULL
substrates	NULL
,	NULL
respectively	NULL
.	NULL

Stimulation	NULL
of	NULL
M12	NULL
cells	NULL
with	NULL
PMA/ionomycin	NULL
induced	NULL
a	NULL
potent	NULL
and	NULL
transient	NULL
activation	NULL
of	NULL
JNK	NULL
which	NULL
reached	NULL
a	NULL
maximum	NULL
after	NULL
30	NULL
min	NULL
.	NULL

However	NULL
,	NULL
this	NULL
treatment	NULL
caused	NULL
only	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
ERK	NULL
activity	NULL
and	NULL
only	NULL
modest	NULL
changes	NULL
in	NULL
p38	NULL
MAP	NULL
kinase	NULL
activity	NULL
were	NULL
detected	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
a	NULL
prominent	NULL
role	NULL
for	NULL
JNK	NULL
rather	NULL
than	NULL
p38	NULL
or	NULL
ERK	NULL
MAP	NULL
kinases	NULL
in	NULL
the	NULL
response	NULL
of	NULL
M12	NULL
cells	NULL
to	NULL
PMA/ionomycin	NULL
.	NULL

422	NULL
We	NULL
then	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
JNK	NULL
signaling	NULL
pathway	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
cytoplasmic	NULL
JNK	NULL
binding	NULL
protein	NULL
JIP-1	NULL
has	NULL
recently	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
nuclear	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
JNK	NULL
pathway	NULL
when	NULL
it	NULL
is	NULL
overexpressed	NULL
(	NULL
Dickens	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
M12	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
or	NULL
without	NULL
JIP-1	NULL
,	NULL
JunB	NULL
or	NULL
c-Jun	NULL
,	NULL
and	NULL
the	NULL
IL-4	NULL
promoter	NULL
reporter	NULL
plasmid	NULL
.	NULL

Figure	NULL
2C	NULL
shows	NULL
that	NULL
JIP-1	NULL
inhibited	NULL
both	NULL
the	NULL
c-Jun-	NULL
and	NULL
JunB-dependent	NULL
activation	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
PMA/	NULL
ionomycin	NULL
stimulation	NULL
.	NULL

We	NULL
further	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
the	NULL
JNK	NULL
signaling	NULL
pathway	NULL
in	NULL
JunB-dependent	NULL
IL-4	NULL
promoter	NULL
activation	NULL
.	NULL

Co-transfection	NULL
of	NULL
MLK3	NULL
,	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
JNK	NULL
pathway	NULL
(	NULL
Rana	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Tibbles	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
together	NULL
with	NULL
JunB	NULL
or	NULL
c-Jun	NULL
dramatically	NULL
enhanced	NULL
IL-4	NULL
promoter	NULL
activity	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
.	NULL

Co-transfection	NULL
of	NULL
another	NULL
JNK	NULL
activator	NULL
MKK7	NULL
(	NULL
Tournier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
together	NULL
with	NULL
JNK1	NULL
also	NULL
enhanced	NULL
JunB-and	NULL
c-Jun-dependent	NULL
IL-4	NULL
promoter	NULL
activation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrated	NULL
that	NULL
JNK	NULL
MAP	NULL
kinase	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
JunB-dependent	NULL
IL-4	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
one	NULL
sense	NULL
our	NULL
results	NULL
with	NULL
JunB	NULL
were	NULL
puzzling	NULL
since	NULL
JunB	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
c-Jun-mediated	NULL
transcription	NULL
(	NULL
Chiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Schutte	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
experiments	NULL
clearly	NULL
established	NULL
JunB	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
JunB	NULL
has	NULL
similar	NULL
activity	NULL
in	NULL
the	NULL
context	NULL
of	NULL
other	NULL
promoters	NULL
,	NULL
we	NULL
used	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
that	NULL
contains	NULL
either	NULL
the	NULL
c-Jun	NULL
promoter	NULL
AP-1	NULL
site	NULL
or	NULL
the	NULL
collagenase	NULL
promoter	NULL
AP-1	NULL
site	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
c-Jun	NULL
activated	NULL
the	NULL
promoters	NULL
when	NULL
co-transfected	NULL
with	NULL
MLK3	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
JunB	NULL
only	NULL
showed	NULL
activity	NULL
at	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

Hence	NULL
,	NULL
transcriptional	NULL
activation	NULL
by	NULL
JunB	NULL
is	NULL
promoter	NULL
specific	NULL
.	NULL

JunB	NULL
is	NULL
phosphorylated	NULL
by	NULL
the	NULL
JNK	NULL
MAP	NULL
kinase	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
is	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
on	NULL
two	NULL
serines	NULL
(	NULL
residues	NULL
63	NULL
and	NULL
73	NULL
)	NULL
by	NULL
the	NULL
JNK	NULL
MAP	NULL
kinase	NULL
(	NULL
Whitmarsh	NULL
and	NULL
Davis	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
these	NULL
phosphorylation	NULL
sites	NULL
are	NULL
not	NULL
conserved	NULL
in	NULL
JunB	NULL
,	NULL
although	NULL
the	NULL
JNK	NULL
binding	NULL
site	NULL
is	NULL
conserved	NULL
in	NULL
both	NULL
c-Jun	NULL
and	NULL
JunB	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
JNK	NULL
binding	NULL
site	NULL
in	NULL
JunB	NULL
suggests	NULL
that	NULL
JunB	NULL
may	NULL
be	NULL
a	NULL
substrate	NULL
for	NULL
JNK	NULL
.	NULL

However	NULL
,	NULL
previous	NULL
studies	NULL
using	NULL
fragments	NULL
of	NULL
JunB	NULL
did	NULL
not	NULL
support	NULL
this	NULL
hypothesis	NULL
(	NULL
Gupta	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Kallunki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
potential	NULL
sites	NULL
of	NULL
JunB	NULL
phosphorylation	NULL
by	NULL
JNK	NULL
using	NULL
full-length	NULL
recombinant	NULL
JunB	NULL
.	NULL

These	NULL
studies	NULL
demonstrated	NULL
that	NULL
JunB	NULL
is	NULL
indeed	NULL
an	NULL
excellent	NULL
substrate	NULL
for	NULL
JNK	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
JunB	NULL
was	NULL
a	NULL
weak	NULL
substrate	NULL
for	NULL
the	NULL
p38	NULL
MAP	NULL
kinase	NULL
and	NULL
was	NULL
not	NULL
significantly	NULL
phosphorylated	NULL
by	NULL
ERK	NULL
MAP	NULL
kinase	NULL
.	NULL

Positive	NULL
control	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
investigating	NULL
the	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
by	NULL
JNK	NULL
,	NULL
ATF2	NULL
by	NULL
p38	NULL
MAP	NULL
kinase	NULL
,	NULL
and	NULL
c-Myc	NULL
by	NULL
ERK2	NULL
to	NULL
ensure	NULL
that	NULL
all	NULL
kinases	NULL
were	NULL
active	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
sequence	NULL
of	NULL
JunB	NULL
revealed	NULL
the	NULL
motif	NULL
Thr-Pro-Thr-Pro	NULL
(	NULL
residues	NULL
102-105	NULL
)	NULL
which	NULL
is	NULL
in	NULL
a	NULL
primary	NULL
sequence	NULL
context	NULL
that	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
sites	NULL
of	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
ATF2	NULL
by	NULL
JNK	NULL
(	NULL
Gupta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
Thr102	NULL
and	NULL
Thr104	NULL
are	NULL
sites	NULL
of	NULL
JunB	NULL
phosphorylation	NULL
by	NULL
JNK	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
replacement	NULL
of	NULL
these	NULL
residues	NULL
with	NULL
Ala	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
sites	NULL
on	NULL
JunB	NULL
phosphorylated	NULL
by	NULL
JNK	NULL
-	NULL
MAP	NULL
kinase	NULL
,	NULL
-	NULL
phosphoamino-acid	NULL
_	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
wild-type	NULL
and	NULL
mutant	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-JunB	NULL
.	NULL

The	NULL
mutant	NULL
JunBala	NULL
protein	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
Thr102	NULL
and	NULL
Thr104	NULL
of	NULL
JunB	NULL
with	NULL
Ala	NULL
residues	NULL
.	NULL

We	NULL
immunopurified	NULL
JNK	NULL
from	NULL
control	NULL
(	NULL
-	NULL
)	NULL
and	NULL
UV-stimulated	NULL
(	NULL
+	NULL
)	NULL
cells	NULL
,	NULL
and	NULL
recombinant	NULL
wild-type	NULL
or	NULL
mutant	NULL
JunB	NULL
proteins	NULL
were	NULL
used	NULL
as	NULL
substrates	NULL
in	NULL
an	NULL
immune	NULL
complex	NULL
protein	NULL
kinase	NULL
assay	NULL
.	NULL

A	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
[	NULL
°°P	NULL
]	NULL
phosphothreonine	NULL
and	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
was	NULL
observed	NULL
with	NULL
wild	NULL
JunB	NULL
regulates	NULL
Th2	NULL
differentiation	NULL
A	NULL
JunB	NULL
_	NULL
c-Jun	NULL
JunB	NULL
_	NULL
ATF2	NULL
JunB	NULL
c-Myc	NULL
100	NULL
&	NULL
T5	NULL
&	NULL
6	NULL
®	NULL
$	NULL
50	NULL
®	NULL
©	NULL
*	NULL
25	NULL
0	NULL
n	NULL
a	NULL
toad	NULL
¢	NULL
3	NULL
&	NULL
gr	NULL
¢	NULL
«	NULL
4	NULL
4	NULL
9	NULL
«	NULL
3	NULL
*	NULL
#	NULL
$	NULL
«	NULL
34	NULL
4	NULL
JNK	NULL
p38	NULL
MAPK	NULL
ERK	NULL
JunB	NULL
JunBala	NULL
B	NULL
*	NULL
*	NULL
~	NULL
*	NULL
UV	NULL
‘	NULL
.	NULL

JunB	NULL
MBL	NULL
<	NULL
p	NULL
Ser	NULL
(	NULL
P	NULL
)	NULL
Wie	NULL
:	NULL
.	NULL

«	NULL
«	NULL
lkthr	NULL
(	NULL
P	NULL
)	NULL
C	NULL
-	NULL
mMLk3	NULL
-	NULL
+	NULL
=	NULL
+	NULL
JNK1	NULL
+	NULL
+	NULL
+	NULL
+	NULL
JunBWT	NULL
JunBala	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

JunB	NULL
is	NULL
phosphorylated	NULL
by	NULL
JNK	NULL
.	NULL

(	NULL
A	NULL
)	NULL
JunB	NULL
is	NULL
a	NULL
better	NULL
substrate	NULL
for	NULL
JNK	NULL
than	NULL
for	NULL
p38	NULL
MAP	NULL
kinase	NULL
or	NULL
ERK	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
(	NULL
pCDNA3	NULL
)	NULL
encoding	NULL
either	NULL
epitope-tagged-JNK1	NULL
,	NULL
-p38a	NULL
MAP	NULL
kinase	NULL
or	NULL
-ERK2	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
UV-C	NULL
(	NULL
80	NULL
J/m	NULL
``	NULL
)	NULL
or	NULL
TPA	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
incubation	NULL
at	NULL
37°C	NULL
(	NULL
60	NULL
and	NULL
15	NULL
min	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Epitope-tagged	NULL
MAP	NULL
kinases	NULL
were	NULL
immunoprecipitated	NULL
and	NULL
the	NULL
MAP	NULL
kinase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
immune	NULL
complex	NULL
by	NULL
protein	NULL
kinase	NULL
assay	NULL
using	NULL
recombinant	NULL
JunB	NULL
,	NULL
c-Jun	NULL
,	NULL
ATF2	NULL
or	NULL
c-Myc	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
phosphorylated	NULL
recombinant	NULL
proteins	NULL
were	NULL
detected	NULL
after	NULL
SDS-PAGE	NULL
by	NULL
autoradiography	NULL
and	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

MAP	NULL
kinase	NULL
activity	NULL
is	NULL
presented	NULL
as	NULL
relative	NULL
protein	NULL
kinase	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
JNK	NULL
phosphorylates	NULL
JunB	NULL
on	NULL
Thr102	NULL
and	NULL
Thr104	NULL
.	NULL

Epitope-tagged-JNK1	NULL
was	NULL
isolated	NULL
by	NULL
immunoprecipitation	NULL
from	NULL
extracts	NULL
of	NULL
cells	NULL
stimulated	NULL
(	NULL
+	NULL
)	NULL
or	NULL
not	NULL
(	NULL
-	NULL
)	NULL
with	NULL
UV-C	NULL
(	NULL
80	NULL
J/m	NULL
``	NULL
)	NULL
for	NULL
60	NULL
min	NULL
and	NULL
used	NULL
for	NULL
protein	NULL
kinase	NULL
assays	NULL
with	NULL
recombinant	NULL
wild-type	NULL
or	NULL
mutant	NULL
JunB	NULL
,	NULL
as	NULL
substrates	NULL
.	NULL

The	NULL
mutant	NULL
JunBala	NULL
protein	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
Thr102	NULL
and	NULL
Thr104	NULL
with	NULL
Ala	NULL
residues	NULL
.	NULL

The	NULL
phosphorylated	NULL
recombinant	NULL
proteins	NULL
were	NULL
detected	NULL
after	NULL
SDS-PAGE	NULL
by	NULL
autoradiography	NULL
and	NULL
were	NULL
analyzed	NULL
by	NULL
analysis	NULL
.	NULL

(	NULL
C	NULL
)	NULL
JunB	NULL
is	NULL
phosphorylated	NULL
on	NULL
Thr102	NULL
and	NULL
Thr104	NULL
in	NULL
M12	NULL
cells	NULL
.	NULL

A	NULL
Flag-tagged	NULL
JunB	NULL
expression	NULL
vector	NULL
was	NULL
co-transfected	NULL
with	NULL
a	NULL
JNK1	NULL
expression	NULL
vector	NULL
with	NULL
or	NULL
without	NULL
MLK3	NULL
expression	NULL
vector	NULL
into	NULL
M12	NULL
cells	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
isolated	NULL
24	NULL
h	NULL
later	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
Flag	NULL
.	NULL

423	NULL
B.Li	NULL
et	NULL
al	NULL
.	NULL

A	NULL
CONTROL	NULL
aNO	NULL
PMA/ION	NULL
JUNB	NULL
NFATp	NULL
NFATe	NULL
Gatas	NULL
CcEBP	NULL
MAF	NULL
JUNB+NFATp	NULL
JUNB+NFATe	NULL
JUNB+GATA3	NULL
JUNB+C/EBP	NULL
JUNB+MAF	NULL
0	NULL
10000	NULL
20000	NULL
30000	NULL
40000	NULL
50000	NULL
60000	NULL
Luciferase/LacZ	NULL
CONTROL	NULL
aN	NULL
PMA/ION	NULL
EPMA/ION	NULL
MAF	NULL
JUND	NULL
JUNB	NULL
CJUN+MAF	NULL
JUND+MAF	NULL
JUNB+MAF	NULL
0	NULL
20000	NULL
40000	NULL
_	NULL
60000	NULL
_	NULL
80000	NULL
Luciferase/LacZ	NULL
CONTROL	NULL
-	NULL
PMA/ION	NULL
BPMA/IO	NULL
N	NULL
Bwt	NULL
(	NULL
21g	NULL
)	NULL
Bwt	NULL
(	NULL
51g	NULL
)	NULL
Bala	NULL
(	NULL
21g	NULL
)	NULL
Bala	NULL
(	NULL
51g	NULL
)	NULL
Bglu	NULL
(	NULL
21g	NULL
)	NULL
[	NULL
g	NULL
Bglu	NULL
(	NULL
Sug	NULL
)	NULL
[	NULL
a	NULL
MAF	NULL
MAF+Bwt	NULL
MAF+Bala	NULL
MAF+Bglu	NULL
0	NULL
2000	NULL
4000	NULL
6000	NULL
8000	NULL
1E+0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
5	NULL
Luciferase/	NULL
LacZ	NULL
FlagJunB	NULL
|	NULL
-	NULL
oy	NULL
$	NULL
G3	NULL
&	NULL
{	NULL
5	NULL
Maf	NULL
>	NULL
0	NULL
8	NULL
s	NULL
to	NULL
4	NULL
o	NULL
wan	NULL
ym	NULL
yay	NULL
pan	NULL
mps	NULL
oue	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

JunB	NULL
activates	NULL
the	NULL
IL-4	NULL
promoter	NULL
synergistically	NULL
with	NULL
c-Maf	NULL
.	NULL

(	NULL
A	NULL
)	NULL
JunB	NULL
and	NULL
c-Maf	NULL
synergistically	NULL
activate	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

Various	NULL
combinations	NULL
of	NULL
expressions	NULL
vectors	NULL
as	NULL
indicated	NULL
were	NULL
co-transfected	NULL
with	NULL
IL-4	NULL
luciferase	NULL
and	NULL
B-gal	NULL
vectors	NULL
into	NULL
M12	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
DNAs	NULL
used	NULL
are	NULL
IL-4	NULL
promoter	NULL
luciferase	NULL
4	NULL
ug	NULL
,	NULL
B-gal	NULL
50	NULL
ng	NULL
,	NULL
c-Maf	NULL
0.8	NULL
ug	NULL
,	NULL
and	NULL
all	NULL
other	NULL
DNAs	NULL
2	NULL
jig	NULL
.	NULL

Luciferase	NULL
and	NULL
LacZ	NULL
values	NULL
were	NULL
determined	NULL
with	NULL
or	NULL
without	NULL
stimulation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Among	NULL
Jun	NULL
family	NULL
members	NULL
only	NULL
JunB	NULL
synergizes	NULL
with	NULL
c-Maf	NULL
to	NULL
activate	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

A	NULL
JunB	NULL
expression	NULL
vector	NULL
was	NULL
co-transfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
different	NULL
transcription	NULL
factors	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
then	NULL
performed	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
DNA	NULL
used	NULL
was	NULL
the	NULL
same	NULL
as	NULL
above	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
synergy	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
was	NULL
enhanced	NULL
by	NULL
JunB	NULL
phosphorylation	NULL
.	NULL

JunB	NULL
wild	NULL
type	NULL
(	NULL
JunB	NULL
)	NULL
,	NULL
JunB	NULL
Thr102/104-	NULL
>	NULL
Ala	NULL
mutant	NULL
(	NULL
JunBala	NULL
)	NULL
and	NULL
JunB	NULL
Thr102/104-Glu	NULL
mutant	NULL
(	NULL
JunBglu	NULL
)	NULL
together	NULL
with	NULL
other	NULL
DNAs	NULL
were	NULL
used	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
JunB	NULL
vectors	NULL
used	NULL
without	NULL
c-Maf	NULL
is	NULL
indicated	NULL
.	NULL

JunB	NULL
vectors	NULL
(	NULL
2	NULL
pug	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
transfection	NULL
when	NULL
both	NULL
JunB	NULL
and	NULL
c-Maf	NULL
were	NULL
co-expressed	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Phosphorylation	NULL
does	NULL
not	NULL
change	NULL
JunB	NULL
protein	NULL
expression	NULL
in	NULL
the	NULL
transfection	NULL
experiment	NULL
.	NULL

Figure	NULL
4C	NULL
was	NULL
repeated	NULL
with	NULL
Flag-tagged	NULL
JunB	NULL
,	NULL
JunBala	NULL
and	NULL
JunBglu	NULL
constructs	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
JunB	NULL
protein	NULL
in	NULL
the	NULL
last	NULL
six	NULL
samples	NULL
of	NULL
Figure	NULL
4C	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
the	NULL
Flag	NULL
epitope	NULL
.	NULL

type	NULL
JunB	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
JunBala	NULL
was	NULL
used	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
JNK	NULL
,	NULL
only	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
was	NULL
observed	NULL
.	NULL

Control	NULL
studies	NULL
were	NULL
performed	NULL
using	NULL
wild-type	NULL
c-Jun	NULL
and	NULL
mutated	NULL
c-Jun	NULL
in	NULL
which	NULL
the	NULL
JNK	NULL
phosphorylation	NULL
sites	NULL
Ser63	NULL
and	NULL
Ser73	NULL
were	NULL
replaced	NULL
with	NULL
Ala	NULL
residues	NULL
(	NULL
c-Junala	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
marked	NULL
serine	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
by	NULL
JNK	NULL
was	NULL
abrogated	NULL
in	NULL
the	NULL
c-Junala	NULL
mutant	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrated	NULL
that	NULL
JunB	NULL
is	NULL
phosphorylated	NULL
by	NULL
JNK	NULL
MAP	NULL
kinase	NULL
on	NULL
Thr102	NULL
and	NULL
Thr1Q04	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
involvement	NULL
of	NULL
JunB	NULL
phosphorylation	NULL
in	NULL
the	NULL
transfection	NULL
assays	NULL
described	NULL
in	NULL
this	NULL
report	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
JunB	NULL
is	NULL
phosphorylated	NULL
in	NULL
M12	NULL
cells	NULL
.	NULL

A	NULL
Flag-tagged	NULL
JunB	NULL
expression	NULL
vector	NULL
was	NULL
co-transfected	NULL
with	NULL
JNK1	NULL
expression	NULL
vector	NULL
with	NULL
or	NULL
without	NULL
424	NULL
a	NULL
MLK3	NULL
expression	NULL
vector	NULL
into	NULL
M12	NULL
cells	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
isolated	NULL
24	NULL
h	NULL
later	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
Flag	NULL
.	NULL

Co-transfection	NULL
of	NULL
MLK3	NULL
induced	NULL
phosphorylation	NULL
of	NULL
JunB	NULL
,	NULL
which	NULL
was	NULL
manifested	NULL
as	NULL
a	NULL
slower-migrating	NULL
band	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
phosphorylated	NULL
,	NULL
slower-migrating	NULL
band	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
co-transfection	NULL
assay	NULL
using	NULL
MLK3	NULL
and	NULL
JunBala	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
M12	NULL
cells	NULL
,	NULL
JunB	NULL
is	NULL
phosphorylated	NULL
on	NULL
Thr102	NULL
and	NULL
Thr104	NULL
residues	NULL
.	NULL

JunB	NULL
and	NULL
c-Maf	NULL
activate	NULL
the	NULL
IL-4	NULL
promoter	NULL
synergistically	NULL
Next	NULL
we	NULL
co-transfected	NULL
with	NULL
JunB	NULL
other	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
known	NULL
to	NULL
activate	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
including	NULL
NFATp	NULL
,	NULL
NFATce	NULL
,	NULL
GATA-3	NULL
,	NULL
C/EBPB	NULL
and	NULL
c-Maf	NULL
.	NULL

Anti	NULL
c-Jun	NULL
+	NULL
Anti	NULL
JunB	NULL
*	NULL
upper	NULL
w-	NULL
.	NULL

--	NULL
-	NULL
supershift	NULL
lower	NULL
*~	NULL
a	NULL
n	NULL
i	NULL
#	NULL
(	NULL
is	NULL
im	NULL
C	NULL
AP-1	NULL
NFAT	NULL
JunB	NULL
regulates	NULL
Th2	NULL
differentiation	NULL
JunB	NULL
c-Jun	NULL
JunD	NULL
3	NULL
y	NULL
t	NULL
g	NULL
t	NULL
G	NULL
5	NULL
t	NULL
G	NULL
a	NULL
f	NULL
f	NULL
2	NULL
f	NULL
f	NULL
a	NULL
f	NULL
f	NULL
E	NULL
d	NULL
2	NULL
E	NULL
0	NULL
z	NULL
5	NULL
o	NULL
z	NULL
wen	NULL
,	NULL
'	NULL
'	NULL
NFAT	NULL
MARE	NULL
Wild	NULL
type	NULL
M	NULL
1	NULL
CTGTGTGCCGCAAATTTTCCAATGTAAACTCATTTCCCTTGGTTTCAGCAACTTTA	NULL
M	NULL
2	NULL
CTGGTGTAATAAACGGGGAAAATGTAAACTCATTTCCCTTGGTTTCAGCAACTTTA	NULL
M3	NULL
CTGGTGTAATAAAATTTTCCAATGTAAACTCCGGGAACTTGGTTTCAGCAACTTTA	NULL
M	NULL
4	NULL
CTGGTGTAATAAAATTTTCCAATGTAAACTCATTTCCCTTGGTTGACTACACTTTA	NULL
S	NULL
a	NULL
c	NULL
©	NULL
&	NULL
D	NULL
a	NULL
0	NULL
gp	NULL
$	NULL
0	NULL
a	NULL
3	NULL
7	NULL
3	NULL
3	NULL
3	NULL
L	NULL
9	NULL
7	NULL
K	NULL
?	NULL

§	NULL
g	NULL
f	NULL
$	NULL
f	NULL
s	NULL
Extract	NULL
I	NULL
3	NULL
5	NULL
3	NULL
3	NULL
5	NULL
PMA/ION	NULL
«	NULL
o	NULL
ee	NULL
oes	NULL
#	NULL
k	NULL
0	NULL
#	NULL
0s	NULL
#	NULL
+o	NULL
+	NULL
+	NULL
+	NULL
DNA	NULL
-	NULL
fragment	NULL
Wild	NULL
type	NULL
M1	NULL
M2	NULL
M	NULL
3	NULL
M4	NULL
cums	NULL
enue	NULL
W	NULL
=	NULL
cames	NULL
w	NULL
«	NULL
--	NULL
-	NULL
tik	NULL
atte	NULL
-~	NULL
CONTROL	NULL
H	NULL
MAF	NULL
JUNB	NULL
JUNB+MAF	NULL
CONTROL	NULL
i	NULL
g	NULL
NO	NULL
PMA/ION	NULL
Eg	NULL
PMA/ION	NULL
IL4p	NULL
WT	NULL
IL4p	NULL
AP-1	NULL
mutant	NULL
JUNB+MAF	NULL
|	NULL
raz	NULL
CONTROL	NULL
if	NULL
MAF	NULL
JUNB	NULL
JUNB+MAF	NULL
IL4p	NULL
MARE	NULL
mutant	NULL
r	NULL
r	NULL
r	NULL
r	NULL
10000	NULL
20000	NULL
30000	NULL
40000	NULL
50000	NULL
0	NULL
A	NULL
synergistic	NULL
effect	NULL
on	NULL
IL-4	NULL
activation	NULL
was	NULL
observed	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
,	NULL
but	NULL
not	NULL
with	NULL
any	NULL
other	NULL
factors	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

While	NULL
c-Maf	NULL
alone	NULL
or	NULL
JunB	NULL
alone	NULL
stimulated	NULL
the	NULL
IL-4	NULL
promoter	NULL
activity	NULL
by	NULL
~6-	NULL
and	NULL
~4-fold	NULL
,	NULL
respectively	NULL
,	NULL
c-Maf	NULL
and	NULL
JunB	NULL
together	NULL
generated	NULL
an	NULL
~50-fold	NULL
stimulation	NULL
.	NULL

Remarkably	NULL
,	NULL
the	NULL
synergy	NULL
between	NULL
c-Maf	NULL
and	NULL
JunB	NULL
was	NULL
specific	NULL
,	NULL
as	NULL
this	NULL
effect	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
JunB	NULL
was	NULL
substituted	NULL
with	NULL
the	NULL
other	NULL
Jun	NULL
family	NULL
members	NULL
c-Jun	NULL
and	NULL
JunD	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
state	NULL
of	NULL
phosphorylation	NULL
of	NULL
JunB	NULL
has	NULL
any	NULL
effect	NULL
on	NULL
the	NULL
synergy	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
,	NULL
we	NULL
co-transfected	NULL
c-Maf	NULL
with	NULL
JunBala	NULL
or	NULL
JunBglu	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

JunB	NULL
binds	NULL
the	NULL
IL-4	NULL
promoter	NULL
synergistically	NULL
with	NULL
c-Maf	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Electrophoretic	NULL
mobility	NULL
shift	NULL
analysis	NULL
(	NULL
EMSA	NULL
)	NULL
of	NULL
the	NULL
P1	NULL
element	NULL
.	NULL

Radiolabeled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
AP-1	NULL
and	NULL
NFAT	NULL
site	NULL
of	NULL
the	NULL
P1	NULL
element	NULL
was	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

Extracts	NULL
are	NULL
made	NULL
from	NULL
activated	NULL
Th2	NULL
cells	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
.	NULL

C-Jun	NULL
and	NULL
JunB	NULL
antibodies	NULL
were	NULL
used	NULL
for	NULL
supershift	NULL
analysis	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Interaction	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
.	NULL

The	NULL
C-terminal	NULL
(	NULL
b-Zip	NULL
domain	NULL
)	NULL
and	NULL
N-terminal	NULL
halves	NULL
of	NULL
c-Maf	NULL
with	NULL
S-tag	NULL
were	NULL
immobilized	NULL
on	NULL
agarose	NULL
.	NULL

In	NULL
vifro	NULL
translated	NULL
c-Jun	NULL
,	NULL
JunB	NULL
and	NULL
JunD	NULL
labeled	NULL
with	NULL
[	NULL
*°S	NULL
}	NULL
methionine	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
beads	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

C-Maf	NULL
and	NULL
N-Maf	NULL
refer	NULL
to	NULL
proteins	NULL
bound	NULL
to	NULL
beads	NULL
coupled	NULL
with	NULL
C-	NULL
and	NULL
N-terminal	NULL
halves	NULL
of	NULL
c-Maf	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
wild-type	NULL
and	NULL
mutant	NULL
DNA	NULL
fragments	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

Sequences	NULL
of	NULL
the	NULL
DNA	NULL
fragment	NULL
spanning	NULL
-87	NULL
to	NULL
-31	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
and	NULL
various	NULL
mutants	NULL
.	NULL

M1	NULL
represents	NULL
the	NULL
DNA	NULL
fragment	NULL
that	NULL
has	NULL
mutated	NULL
the	NULL
P1	NULL
AP-1	NULL
site	NULL
;	NULL
in	NULL
similar	NULL
fashion	NULL
:	NULL
M2	NULL
,	NULL
P1	NULL
NFAT	NULL
;	NULL
M3	NULL
,	NULL
PO	NULL
NFAT	NULL
;	NULL
M4	NULL
,	NULL
MARE	NULL
.	NULL

(	NULL
D	NULL
)	NULL
C-Maf	NULL
binding	NULL
to	NULL
IL-4	NULL
promoter	NULL
DNA	NULL
is	NULL
facilitated	NULL
by	NULL
phosphorylated	NULL
JunB	NULL
.	NULL

Wild-type	NULL
or	NULL
mutant	NULL
DNA	NULL
fragments	NULL
were	NULL
incubated	NULL
with	NULL
c-Maf	NULL
beads	NULL
and	NULL
with	NULL
or	NULL
without	NULL
various	NULL
protein	NULL
preparations	NULL
as	NULL
indicated	NULL
.	NULL

Bound	NULL
DNA	NULL
fragments	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
non-denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

(	NULL
E	NULL
)	NULL
The	NULL
AP-1	NULL
and	NULL
MARE	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
synergistic	NULL
activation	NULL
of	NULL
IL-4	NULL
promoter	NULL
by	NULL
JunB	NULL
and	NULL
c-Maf	NULL
.	NULL

IL-4	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
with	NULL
either	NULL
the	NULL
AP-1	NULL
site	NULL
or	NULL
the	NULL
MARE	NULL
site	NULL
mutated	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
IL-4	NULL
promoter	NULL
construct	NULL
with	NULL
a	NULL
luciferase	NULL
assay	NULL
.	NULL

mutants	NULL
.	NULL

JunBglu	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
Thr102	NULL
and	NULL
Thr104	NULL
with	NULL
glutamic	NULL
acid	NULL
residues	NULL
.	NULL

JunBglu	NULL
would	NULL
therefore	NULL
be	NULL
expected	NULL
to	NULL
mimic	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
JunB	NULL
.	NULL

Both	NULL
mutants	NULL
and	NULL
the	NULL
wild-type	NULL
JunB	NULL
vector	NULL
when	NULL
co-transfected	NULL
alone	NULL
with	NULL
the	NULL
IL-4	NULL
reporter	NULL
gene	NULL
generated	NULL
modest	NULL
activation	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
Figure	NULL
4C	NULL
)	NULL
.	NULL

Although	NULL
there	NULL
was	NULL
still	NULL
some	NULL
synergy	NULL
with	NULL
c-Maf	NULL
when	NULL
JunBala	NULL
was	NULL
co-transfected	NULL
,	NULL
the	NULL
activity	NULL
was	NULL
lower	NULL
than	NULL
when	NULL
wild-type	NULL
JunB	NULL
was	NULL
used	NULL
.	NULL

However	NULL
,	NULL
the	NULL
JunBglu	NULL
mutant	NULL
generated	NULL
a	NULL
very	NULL
potent	NULL
synergy	NULL
with	NULL
c-Maf	NULL
in	NULL
activating	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
that	NULL
phosphorylation	NULL
of	NULL
JunB	NULL
enhanced	NULL
its	NULL
ability	NULL
to	NULL
425	NULL
B.Li	NULL
et	NULL
al	NULL
.	NULL

synergize	NULL
with	NULL
c-Maf	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

Since	NULL
the	NULL
protein	NULL
stability	NULL
of	NULL
c-Jun	NULL
is	NULL
known	NULL
to	NULL
be	NULL
influenced	NULL
by	NULL
phosphorylation	NULL
(	NULL
Ip	NULL
and	NULL
Davis	NULL
,	NULL
1998	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
JunB	NULL
protein	NULL
level	NULL
in	NULL
the	NULL
above	NULL
transfection	NULL
experiments	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
JunB	NULL
and	NULL
JunB-mutant	NULL
proteins	NULL
were	NULL
detected	NULL
in	NULL
each	NULL
sample	NULL
regardless	NULL
of	NULL
the	NULL
status	NULL
of	NULL
PMA/ionomycin	NULL
treatment	NULL
or	NULL
c-Maf	NULL
co-transfection	NULL
(	NULL
Figure	NULL
4D	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
different	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
measured	NULL
using	NULL
the	NULL
different	NULL
JunB	NULL
proteins	NULL
was	NULL
not	NULL
caused	NULL
by	NULL
changes	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
JunB	NULL
protein	NULL
.	NULL

Cooperative	NULL
binding	NULL
of	NULL
JunB	NULL
and	NULL
c-Maf	NULL
to	NULL
IL-4	NULL
promoter	NULL
DNA	NULL
Previous	NULL
gel-shift	NULL
experiments	NULL
using	NULL
the	NULL
Th2	NULL
cell-specific	NULL
P1	NULL
element	NULL
showed	NULL
that	NULL
JunB	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
(	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Extracts	NULL
from	NULL
Th2	NULL
cells	NULL
cultured	NULL
from	NULL
primary	NULL
T	NULL
cells	NULL
form	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
shifted	NULL
bands	NULL
on	NULL
the	NULL
P1	NULL
element	NULL
(	NULL
Wenner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
and	NULL
competition	NULL
experiments	NULL
using	NULL
various	NULL
oligonucleotides	NULL
showed	NULL
that	NULL
the	NULL
AP-1	NULL
site	NULL
was	NULL
bound	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
JunB	NULL
is	NULL
the	NULL
AP-1	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
P1	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
gel-shift	NULL
experiments	NULL
using	NULL
P1	NULL
oligonucleotides	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
day	NULL
3	NULL
Th2	NULL
cells	NULL
differentiated	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
double-shifted	NULL
bands	NULL
characteristic	NULL
of	NULL
the	NULL
P1	NULL
element	NULL
were	NULL
formed	NULL
,	NULL
and	NULL
the	NULL
upper	NULL
band	NULL
was	NULL
supershifted	NULL
by	NULL
JunB	NULL
antibody	NULL
but	NULL
not	NULL
by	NULL
c-Jun	NULL
antibody	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

The	NULL
synergy	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
JunB	NULL
interacts	NULL
directly	NULL
with	NULL
c-Maf	NULL
,	NULL
since	NULL
c-Jun	NULL
was	NULL
known	NULL
to	NULL
bind	NULL
c-Maf	NULL
directly	NULL
(	NULL
Kerppola	NULL
and	NULL
Curran	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
indirect	NULL
interaction	NULL
through	NULL
a	NULL
common	NULL
binding	NULL
partner	NULL
,	NULL
a	NULL
transcriptional	NULL
co-activator	NULL
for	NULL
example	NULL
,	NULL
was	NULL
also	NULL
possible	NULL
We	NULL
expressed	NULL
both	NULL
the	NULL
C-terminal	NULL
half	NULL
b-Zip	NULL
domain	NULL
and	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
recombinant	NULL
c-Maf	NULL
protein	NULL
in	NULL
Escherichia	NULL
coli	NULL
,	NULL
and	NULL
immobilized	NULL
the	NULL
purified	NULL
proteins	NULL
on	NULL
agarose	NULL
beads	NULL
taking	NULL
advantage	NULL
of	NULL
the	NULL
S-tag	NULL
in	NULL
the	NULL
expression	NULL
vector	NULL
construct	NULL
.	NULL

We	NULL
incubated	NULL
the	NULL
beads	NULL
with	NULL
radiolabeled	NULL
JunB	NULL
,	NULL
c-Jun	NULL
or	NULL
JunD	NULL
protein	NULL
obtained	NULL
from	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
reactions	NULL
.	NULL

Both	NULL
JunB	NULL
and	NULL
c-Jun	NULL
bound	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
c-Maf	NULL
which	NULL
contains	NULL
the	NULL
leucine-zipper	NULL
motif	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
JunD	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
either	NULL
moiety	NULL
of	NULL
c-Maf	NULL
.	NULL

c-Maf	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
bind	NULL
the	NULL
MARE	NULL
half	NULL
site	NULL
around	NULL
-40	NULL
bp	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
JunB	NULL
also	NULL
bound	NULL
this	NULL
site	NULL
,	NULL
potentially	NULL
in	NULL
cooperation	NULL
with	NULL
c-Maf	NULL
.	NULL

However	NULL
,	NULL
an	NULL
EMSA	NULL
experiment	NULL
using	NULL
a	NULL
probe	NULL
of	NULL
-62	NULL
to	NULL
-25	NULL
bp	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
did	NULL
not	NULL
form	NULL
any	NULL
bands	NULL
that	NULL
could	NULL
be	NULL
supershifted	NULL
by	NULL
JunB	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
JunB	NULL
potentiated	NULL
the	NULL
binding	NULL
of	NULL
c-Maf	NULL
to	NULL
DNA	NULL
,	NULL
we	NULL
took	NULL
beads	NULL
carrying	NULL
immobilized	NULL
c-Maf	NULL
and	NULL
added	NULL
in	NULL
vitro	NULL
translated	NULL
JunB	NULL
and	NULL
radiolabeled	NULL
DNA	NULL
fragments	NULL
spanning	NULL
bps	NULL
-87	NULL
to	NULL
-31	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
and	NULL
various	NULL
mutants	NULL
of	NULL
this	NULL
DNA	NULL
element	NULL
(	NULL
sequences	NULL
listed	NULL
in	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
substantial	NULL
increase	NULL
in	NULL
bound	NULL
DNA	NULL
when	NULL
in	NULL
vitro-translated	NULL
JunB	NULL
was	NULL
used	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
did	NULL
see	NULL
a	NULL
large	NULL
increase	NULL
in	NULL
DNA	NULL
bound	NULL
to	NULL
c-Maf	NULL
when	NULL
we	NULL
substituted	NULL
the	NULL
in	NULL
vitro-translated	NULL
JunB	NULL
with	NULL
extracts	NULL
from	NULL
M12	NULL
cells	NULL
transfected	NULL
with	NULL
JunB	NULL
and	NULL
treated	NULL
with	NULL
PMA/ionomycin	NULL
(	NULL
Figure	NULL
5D	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
see	NULL
the	NULL
increase	NULL
when	NULL
using	NULL
426	NULL
CD4	NULL
promoter/	NULL
enhancer	NULL
-t	NULL
»	NULL
-W	NULL
»	NULL
-	NULL
JunB	NULL
Spliced	NULL
mRNA	NULL
B	NULL
WT	NULL
110	NULL
58	NULL
60	NULL
62	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
C	NULL
WT	NULL
58	NULL
60	NULL
62	NULL
JunB	NULL
*~*	NULL
#	NULL
=*	NULL
te	NULL
#	NULL
tat	NULL
ACtIN	NULL
-	NULL
«	NULL
«	NULL
soe	NULL
mae	NULL
mit	NULL
D	NULL
120000	NULL
G	NULL
Unstimulated	NULL
100000	NULL
@	NULL
Stimulated	NULL
|	NULL
3	NULL
&	NULL
sooo	NULL
0	NULL
£	NULL
&	NULL
s00t0	NULL
3	NULL
0	NULL
£	NULL
°	NULL
40000	NULL
€	NULL
£	NULL
f	NULL
20000	NULL
o	NULL
wT	NULL
11	NULL
se	NULL
60	NULL
62	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Expression	NULL
of	NULL
JunB	NULL
in	NULL
CD4-JunB	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
CD4-JunB	NULL
transgene	NULL
.	NULL

The	NULL
JunB	NULL
cDNA	NULL
was	NULL
fused	NULL
with	NULL
the	NULL
second	NULL
exon	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
.	NULL

The	NULL
arrow	NULL
at	NULL
the	NULL
bottom	NULL
indicates	NULL
the	NULL
downstream	NULL
primer	NULL
used	NULL
for	NULL
screening	NULL
both	NULL
the	NULL
transgene	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
transgene	NULL
mRNA	NULL
.	NULL

The	NULL
first	NULL
arrow	NULL
from	NULL
the	NULL
left	NULL
above	NULL
the	NULL
construct	NULL
indicates	NULL
the	NULL
primer	NULL
used	NULL
for	NULL
screening	NULL
the	NULL
transgene	NULL
mRNA	NULL
in	NULL
RT-PCR	NULL
.	NULL

The	NULL
second	NULL
arrow	NULL
indicates	NULL
the	NULL
primer	NULL
used	NULL
for	NULL
screening	NULL
the	NULL
transgene	NULL
incorporation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RT-PCR	NULL
showing	NULL
expression	NULL
of	NULL
transgene	NULL
in	NULL
mice	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
T	NULL
cells	NULL
in	NULL
peripheral	NULL
blood	NULL
of	NULL
transgene	NULL
positive	NULL
mice	NULL
and	NULL
wild-type	NULL
littermates	NULL
.	NULL

RT-PCR	NULL
was	NULL
done	NULL
using	NULL
primers	NULL
described	NULL
in	NULL
Figure	NULL
1A	NULL
and	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

B-tubulin	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Increase	NULL
of	NULL
JunB	NULL
protein	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

JunB	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
done	NULL
with	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
lymph	NULL
nodes	NULL
of	NULL
transgenic	NULL
mice	NULL
and	NULL
wild-type	NULL
littermates	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
polyclonal	NULL
antibody	NULL
against	NULL
actin	NULL
was	NULL
used	NULL
as	NULL
a	NULL
loading	NULL
control	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Normal	NULL
proliferation	NULL
of	NULL
transgenic	NULL
T	NULL
cells	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
transgenic	NULL
mice	NULL
or	NULL
wild-type	NULL
littermates	NULL
and	NULL
cultured	NULL
with	NULL
ConA	NULL
,	NULL
IL-2	NULL
and	NULL
APC	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
methods	NULL
)	NULL
for	NULL
2	NULL
days	NULL
and	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
was	NULL
added	NULL
.	NULL

Radioactivity	NULL
incorporation	NULL
was	NULL
measured	NULL
18	NULL
h	NULL
later	NULL
in	NULL
triplicate	NULL
.	NULL

extracts	NULL
from	NULL
c-Jun	NULL
transfected	NULL
cells	NULL
,	NULL
which	NULL
argues	NULL
that	NULL
JunB	NULL
specifically	NULL
increased	NULL
c-Maf	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

Signi-ficantly	NULL
,	NULL
PMA/ionomycin	NULL
treatment	NULL
was	NULL
required	NULL
to	NULL
increase	NULL
DNA	NULL
binding	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
JunB	NULL
phosphorylation	NULL
may	NULL
be	NULL
required	NULL
since	NULL
PMA/ionomycin	NULL
dramatically	NULL
induces	NULL
JNK	NULL
activity	NULL
.	NULL

We	NULL
tested	NULL
this	NULL
hypothesis	NULL
by	NULL
using	NULL
extracts	NULL
from	NULL
JunBala	NULL
or	NULL
JunBglu	NULL
transfected	NULL
cells	NULL
.	NULL

Extracts	NULL
from	NULL
JunBala	NULL
transfected	NULL
cells	NULL
did	NULL
not	NULL
JunB	NULL
regulates	NULL
Th2	NULL
differentiation	NULL
A	NULL
-s	NULL
350	NULL
C	NULL
f	NULL
2	NULL
m	NULL
a	NULL
__	NULL
300	NULL
;	NULL
60	NULL
|-w	NULL
&	NULL
E	NULL
250	NULL
|	NULL
&	NULL
50	NULL
|	NULL
Rs	NULL
e	NULL
e	NULL
@	NULL
200	NULL
|	NULL
£40	NULL
|	NULL
&	NULL
E	NULL
&	NULL
L	NULL
3	NULL
.	NULL

a	NULL
£4	NULL
&	NULL
150	NULL
3	NULL
30	NULL
ig	NULL
1090	NULL
|	NULL
3	NULL
20	NULL
|	NULL
=	NULL
1	NULL
=l	NULL
50	NULL
|	NULL
-	NULL
TD	NULL
C	NULL
B-tubulin	NULL
pf	NULL
o	NULL
T	NULL
o	NULL
©	NULL
T	NULL
o	NULL
M	NULL
T	NULL
o	NULL
m	NULL
z	NULL
8	NULL
og	NULL
=	NULL
£	NULL
oc	NULL
T	NULL
B	NULL
og	NULL
-	NULL
L4	NULL
**	NULL
E	NULL
:	NULL
**	NULL
3	NULL
,	NULL
ga	NULL
E	NULL
:	NULL
350	NULL
;	NULL
1000	NULL
__	NULL
300	NULL
|	NULL
_	NULL
--	NULL
E	NULL
200	NULL
|	NULL
E	NULL
soo	NULL
2200	NULL
-	NULL
g	NULL
600	NULL
+-*	NULL
150	NULL
|	NULL
|	NULL
400	NULL
u	NULL
,	NULL
109	NULL
|	NULL
5	NULL
|L1D	NULL
g	NULL
50	NULL
3	NULL
200	NULL
|	NULL
0	NULL
~	NULL
k	NULL
s	NULL
o	NULL
®	NULL
3	NULL
o	NULL
®	NULL
D	NULL
250	NULL
E	NULL
100	NULL
F	NULL
90000	NULL
pa	NULL
-O-Wild	NULL
Type	NULL
-O-Wild	NULL
Type	NULL
2	NULL
so000	NULL
}	NULL
E	NULL
.	NULL

|	NULL
{	NULL
-	NULL
@	NULL
-JunB	NULL
pa	NULL
|	NULL
.	NULL

\	NULL
-	NULL
@	NULL
-JunB	NULL
L	NULL
a	NULL
.	NULL

£	NULL
200	NULL
<	NULL
80	NULL
&	NULL
7oo0o	NULL
|	NULL
3	NULL
E	NULL
~	NULL
``	NULL
_	NULL
150	NULL
3	NULL
cso	NULL
|	NULL
&	NULL
60000	NULL
.	NULL

Lo	NULL
g	NULL
|	NULL
&	NULL
100	NULL
3	NULL
§	NULL
50000	NULL
it	NULL
&	NULL
040	NULL
f	NULL
|	NULL
_	NULL
§	NULL
40000	NULL
|	NULL
50	NULL
2	NULL
soo00	NULL
|	NULL
o	NULL
29	NULL
[	NULL
L	NULL
,	NULL
20000	NULL
|	NULL
5	NULL
0	NULL
QL	NULL
[	NULL
10	NULL
100	NULL
o	NULL
8	NULL
10000	NULL
|	NULL
H	NULL
(	NULL
ug/ml	NULL
)	NULL
0	NULL
1	NULL
10	NULL
100	NULL
5	NULL
0	NULL
ln	NULL
wild	NULL
JunB	NULL
KLH	NULL
(	NULL
ug/ml	NULL
)	NULL
Type	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Upregulation	NULL
of	NULL
Th2	NULL
cytokines	NULL
in	NULL
JunB	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RT-PCR	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
transgenic	NULL
or	NULL
wild-type	NULL
littermates	NULL
and	NULL
differentiated	NULL
in	NULL
vitro	NULL
toward	NULL
Th1	NULL
using	NULL
ConA	NULL
,	NULL
IL-12	NULL
and	NULL
anti-IL-4	NULL
antibody	NULL
.	NULL

Three	NULL
days	NULL
later	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
cytokine	NULL
RT-PCR	NULL
was	NULL
done	NULL
.	NULL

B-tubulin	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
ELISA	NULL
.	NULL

Cytokine	NULL
ELISA	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
supernatant	NULL
of	NULL
the	NULL
day	NULL
3	NULL
culture	NULL
used	NULL
in	NULL
Figure	NULL
7A	NULL
.	NULL

Average	NULL
values	NULL
from	NULL
line	NULL
58	NULL
and	NULL
line	NULL
62	NULL
were	NULL
used	NULL
for	NULL
the	NULL
graph	NULL
.	NULL

(	NULL
C	NULL
)	NULL
In	NULL
vitro	NULL
T	NULL
cell	NULL
differentiation	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
7A	NULL
except	NULL
that	NULL
no	NULL
anti-IL-4	NULL
antibody	NULL
was	NULL
added	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
IL-4	NULL
secreted	NULL
was	NULL
examined	NULL
by	NULL
cytokine	NULL
ELISA	NULL
.	NULL

(	NULL
D	NULL
and	NULL
E	NULL
)	NULL
Cytokine	NULL
production	NULL
in	NULL
KLH-immunized	NULL
mice	NULL
.	NULL

T	NULL
cells	NULL
from	NULL
draining	NULL
lymph	NULL
node	NULL
of	NULL
KLH	NULL
immunized	NULL
mice	NULL
were	NULL
cultured	NULL
with	NULL
various	NULL
amount	NULL
of	NULL
KLH	NULL
for	NULL
4	NULL
days	NULL
.	NULL

IL-4	NULL
and	NULL
IFN-y	NULL
was	NULL
measured	NULL
using	NULL
ELISA	NULL
.	NULL

The	NULL
wild-type	NULL
mice	NULL
used	NULL
were	NULL
the	NULL
transgene	NULL
negative	NULL
littermates	NULL
.	NULL

(	NULL
F	NULL
)	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
at	NULL
day	NULL
3	NULL
and	NULL
incorporation	NULL
of	NULL
radioactivity	NULL
was	NULL
measured	NULL
18	NULL
h	NULL
later	NULL
in	NULL
triplicate	NULL
.	NULL

facilitate	NULL
DNA	NULL
binding	NULL
even	NULL
with	NULL
PMA/ionomycin	NULL
treat-ment	NULL
,	NULL
while	NULL
extracts	NULL
from	NULL
JunBglu	NULL
transfected	NULL
cells	NULL
were	NULL
sufficient	NULL
to	NULL
mediate	NULL
binding	NULL
even	NULL
without	NULL
PMA/ionomycin	NULL
treatment	NULL
.	NULL

These	NULL
experiments	NULL
argue	NULL
strongly	NULL
that	NULL
the	NULL
cooperative	NULL
DNA	NULL
binding	NULL
of	NULL
JunB	NULL
and	NULL
c-Maf	NULL
is	NULL
facilitated	NULL
by	NULL
JunB	NULL
phosphorylation	NULL
.	NULL

To	NULL
map	NULL
the	NULL
DNA	NULL
sequence	NULL
that	NULL
is	NULL
required	NULL
for	NULL
this	NULL
cooperative	NULL
binding	NULL
,	NULL
we	NULL
used	NULL
the	NULL
-87/-31	NULL
bp	NULL
fragment	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
with	NULL
mutations	NULL
at	NULL
various	NULL
sites	NULL
.	NULL

Mutations	NULL
at	NULL
the	NULL
P1	NULL
AP-1	NULL
site	NULL
and	NULL
the	NULL
MARE	NULL
half	NULL
site	NULL
greatly	NULL
reduced	NULL
DNA	NULL
binding	NULL
while	NULL
mutations	NULL
at	NULL
either	NULL
NFAT	NULL
sites	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
Figure	NULL
5D	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
indicated	NULL
that	NULL
JunB	NULL
and	NULL
c-Maf	NULL
bind	NULL
distant	NULL
elements	NULL
(	NULL
centered	NULL
on	NULL
-80	NULL
and	NULL
-40	NULL
,	NULL
respectively	NULL
)	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
and	NULL
that	NULL
cooperativity	NULL
of	NULL
binding	NULL
is	NULL
facilitated	NULL
through	NULL
JunB	NULL
phosphorylation	NULL
.	NULL

To	NULL
test	NULL
further	NULL
whether	NULL
the	NULL
AP-1	NULL
and	NULL
MARE	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
JunB	NULL
and	NULL
c-Maf	NULL
mediated	NULL
synergistic	NULL
activation	NULL
of	NULL
IL-4	NULL
promoter	NULL
,	NULL
we	NULL
generated	NULL
IL-4	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
with	NULL
either	NULL
the	NULL
AP-1	NULL
site	NULL
or	NULL
the	NULL
MARE	NULL
site	NULL
mutated	NULL
.	NULL

Figure	NULL
5E	NULL
shows	NULL
that	NULL
both	NULL
constructs	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
support	NULL
synergistic	NULL
promoter	NULL
activation	NULL
by	NULL
JunB	NULL
and	NULL
c-Maf	NULL
in	NULL
luciferase	NULL
assays	NULL
.	NULL

Thus	NULL
,	NULL
synergy	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
requires	NULL
functional	NULL
AP-1	NULL
and	NULL
MARE	NULL
sites	NULL
.	NULL

Upregulation	NULL
of	NULL
cytokines	NULL
in	NULL
differentiating	NULL
Th1	NULL
cells	NULL
from	NULL
JunB	NULL
transgenic	NULL
mice	NULL
To	NULL
examine	NULL
whether	NULL
JunB	NULL
plays	NULL
a	NULL
causal	NULL
role	NULL
in	NULL
Th2	NULL
cytokine	NULL
expression	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
generated	NULL
transgenic	NULL
mice	NULL
that	NULL
express	NULL
JunB	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
CD4	NULL
promoter	NULL
construct	NULL
we	NULL
employed	NULL
lacks	NULL
the	NULL
CD4	NULL
silencer	NULL
,	NULL
JunB	NULL
is	NULL
expressed	NULL
in	NULL
both	NULL
CD4	NULL
and	NULL
CD8	NULL
cells	NULL
(	NULL
Killeen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
JunB	NULL
transgene	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
was	NULL
verified	NULL
by	NULL
RT-PCR	NULL
using	NULL
one	NULL
primer	NULL
derived	NULL
from	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
CD4	NULL
gene	NULL
and	NULL
the	NULL
other	NULL
primer	NULL
from	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
JunB	NULL
cDNA	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
nine	NULL
transgenic	NULL
lines	NULL
generated	NULL
,	NULL
four	NULL
lines	NULL
tested	NULL
positive	NULL
for	NULL
transgene	NULL
expression	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
line	NULL
62	NULL
has	NULL
a	NULL
higher	NULL
copy	NULL
number	NULL
and	NULL
higher	NULL
expression	NULL
level	NULL
than	NULL
other	NULL
lines	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

We	NULL
then	NULL
examined	NULL
JunB	NULL
protein	NULL
levels	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
.	NULL

JunB	NULL
protein	NULL
was	NULL
significantly	NULL
increased	NULL
in	NULL
transgenic	NULL
mice	NULL
compared	NULL
with	NULL
wild-type	NULL
littermates	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
this	NULL
increase	NULL
is	NULL
roughly	NULL
equivalent	NULL
to	NULL
the	NULL
427	NULL
B.Li	NULL
et	NULL
al	NULL
.	NULL

increase	NULL
of	NULL
the	NULL
endogenous	NULL
JunB	NULL
protein	NULL
in	NULL
Th2	NULL
cells	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
JunB	NULL
transgene	NULL
did	NULL
not	NULL
have	NULL
any	NULL
overt	NULL
effect	NULL
on	NULL
lymphocyte	NULL
development	NULL
since	NULL
the	NULL
transgenic	NULL
lines	NULL
had	NULL
normal	NULL
profiles	NULL
of	NULL
thymocyte	NULL
subpopu-lations	NULL
staining	NULL
for	NULL
CD4	NULL
and	NULL
CDS	NULL
and	NULL
spleen	NULL
cells	NULL
(	NULL
CD4	NULL
and	NULL
CD8	NULL
cells	NULL
,	NULL
and	NULL
B	NULL
cells	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
proliferation	NULL
of	NULL
naive	NULL
CD4	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
Con	NULL
A	NULL
,	NULL
IL-2	NULL
and	NULL
APC	NULL
was	NULL
slightly	NULL
enhanced	NULL
in	NULL
the	NULL
transgenic	NULL
lines	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
littermates	NULL
(	NULL
Figure	NULL
6D	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
JunB	NULL
is	NULL
sufficient	NULL
to	NULL
turn	NULL
on	NULL
Th2	NULL
cytokine	NULL
expression	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
JunB	NULL
transgene	NULL
in	NULL
Th1	NULL
cells	NULL
,	NULL
a	NULL
condition	NULL
where	NULL
Th2	NULL
cytokine	NULL
expression	NULL
is	NULL
not	NULL
usually	NULL
observed	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
elevation	NULL
of	NULL
the	NULL
JunB	NULL
level	NULL
in	NULL
Th1	NULL
cells	NULL
by	NULL
transgenesis	NULL
to	NULL
an	NULL
equivalent	NULL
level	NULL
as	NULL
found	NULL
in	NULL
Th2	NULL
cells	NULL
would	NULL
test	NULL
whether	NULL
JunB	NULL
plays	NULL
a	NULL
similar	NULL
role	NULL
in	NULL
Th2	NULL
differentiation	NULL
.	NULL

Naive	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
transgene-positive	NULL
animals	NULL
and	NULL
negative	NULL
littermates	NULL
were	NULL
differentiated	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
Th1	NULL
subset	NULL
by	NULL
culture	NULL
with	NULL
ConA	NULL
plus	NULL
IL-2	NULL
,	NULL
IL-12	NULL
and	NULL
anti-IL-4	NULL
mAb	NULL
for	NULL
3	NULL
days	NULL
,	NULL
by	NULL
which	NULL
time	NULL
T	NULL
helper	NULL
cells	NULL
have	NULL
already	NULL
differentiated	NULL
to	NULL
produce	NULL
the	NULL
corresponding	NULL
cytokines	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
several	NULL
cytokines	NULL
were	NULL
examined	NULL
by	NULL
RT-PCR	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

In	NULL
both	NULL
transgenic	NULL
lines	NULL
examined	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IFN-y	NULL
was	NULL
essentially	NULL
the	NULL
same	NULL
as	NULL
that	NULL
in	NULL
the	NULL
wild-type	NULL
littermate	NULL
controls	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
much	NULL
higher	NULL
level	NULL
of	NULL
IL-4	NULL
and	NULL
IL-5	NULL
mRNA	NULL
was	NULL
observed	NULL
in	NULL
both	NULL
transgenic	NULL
lines	NULL
than	NULL
in	NULL
the	NULL
negative	NULL
littermate	NULL
controls	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
IL-6	NULL
and	NULL
IL-10	NULL
were	NULL
also	NULL
increased	NULL
.	NULL

The	NULL
slightly	NULL
stronger	NULL
signal	NULL
seen	NULL
in	NULL
line	NULL
62	NULL
corresponded	NULL
with	NULL
its	NULL
higher	NULL
level	NULL
of	NULL
JunB	NULL
expression	NULL
than	NULL
in	NULL
other	NULL
lines	NULL
.	NULL

To	NULL
quantitate	NULL
the	NULL
amount	NULL
of	NULL
cytokines	NULL
produced	NULL
in	NULL
the	NULL
culture	NULL
,	NULL
we	NULL
performed	NULL
ELISA	NULL
with	NULL
the	NULL
supernatant	NULL
of	NULL
the	NULL
day	NULL
3	NULL
culture	NULL
used	NULL
above	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
.	NULL

In	NULL
the	NULL
transgenic	NULL
T	NULL
cells	NULL
,	NULL
IFN-y	NULL
remained	NULL
unchanged	NULL
at	NULL
high	NULL
level	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
IL-5	NULL
was	NULL
increased	NULL
by	NULL
3-	NULL
to	NULL
4-fold	NULL
;	NULL
the	NULL
amount	NULL
of	NULL
IL-6	NULL
and	NULL
IL-10	NULL
were	NULL
both	NULL
increased	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
.	NULL

IL-4	NULL
secretion	NULL
by	NULL
both	NULL
wild-type	NULL
and	NULL
transgenic	NULL
cells	NULL
was	NULL
virtually	NULL
undetectable	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
anti-IL-4	NULL
mAb	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
to	NULL
skew	NULL
the	NULL
response	NULL
toward	NULL
Th1	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
quantitate	NULL
the	NULL
difference	NULL
in	NULL
IL-4	NULL
secretion	NULL
,	NULL
we	NULL
repeated	NULL
the	NULL
above	NULL
experiment	NULL
without	NULL
anti-IL-4	NULL
mAb	NULL
.	NULL

ELISA	NULL
measurements	NULL
showed	NULL
that	NULL
T	NULL
cells	NULL
from	NULL
JunB	NULL
transgenic	NULL
mice	NULL
produced	NULL
4-	NULL
to	NULL
5-fold	NULL
more	NULL
IL-4	NULL
than	NULL
negative	NULL
littermates	NULL
(	NULL
Figure	NULL
7C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
that	NULL
overexpression	NULL
of	NULL
JunB	NULL
was	NULL
sufficient	NULL
to	NULL
turn	NULL
on	NULL
Th2	NULL
cytokine	NULL
expression	NULL
,	NULL
even	NULL
in	NULL
a	NULL
Th1l	NULL
population	NULL
.	NULL

Upregulation	NULL
of	NULL
IL-4	NULL
in	NULL
antigen	NULL
re-stimulated	NULL
T	NULL
cells	NULL
from	NULL
KLH-immunized	NULL
mice	NULL
To	NULL
test	NULL
whether	NULL
JunB	NULL
transgenic	NULL
T	NULL
cells	NULL
were	NULL
predisposed	NULL
to	NULL
develop	NULL
into	NULL
IL-4	NULL
producing	NULL
cells	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
immunized	NULL
mice	NULL
using	NULL
Keyhole	NULL
Limpet	NULL
Hemocyanin	NULL
(	NULL
KLH	NULL
)	NULL
with	NULL
complete	NULL
Freund	NULL
's	NULL
Adjuvant	NULL
(	NULL
CFA	NULL
)	NULL
and	NULL
harvested	NULL
T	NULL
cells	NULL
from	NULL
draining	NULL
lymph	NULL
nodes	NULL
after	NULL
9	NULL
days	NULL
.	NULL

Cytokine	NULL
production	NULL
by	NULL
these	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
KLH	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
(	NULL
Figure	NULL
7D	NULL
and	NULL
E	NULL
)	NULL
.	NULL

KLH	NULL
in	NULL
CFA	NULL
elicits	NULL
an	NULL
immune	NULL
reaction	NULL
skewed	NULL
toward	NULL
Thl	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
we	NULL
saw	NULL
a	NULL
relatively	NULL
high	NULL
level	NULL
of	NULL
IFN-y	NULL
production	NULL
using	NULL
wild-type	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
IFN-y	NULL
produced	NULL
in	NULL
transgenic	NULL
T	NULL
cells	NULL
,	NULL
however	NULL
,	NULL
was	NULL
slightly	NULL
lower	NULL
(	NULL
Figure	NULL
7D	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
although	NULL
the	NULL
amount	NULL
of	NULL
IL-4	NULL
produced	NULL
in	NULL
both	NULL
wild	NULL
428	NULL
type	NULL
and	NULL
transgenic	NULL
cells	NULL
was	NULL
quite	NULL
low	NULL
,	NULL
there	NULL
was	NULL
a	NULL
consistently	NULL
higher	NULL
amount	NULL
of	NULL
IL-4	NULL
produced	NULL
by	NULL
the	NULL
transgenic	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
7E	NULL
)	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
the	NULL
proliferative	NULL
ability	NULL
of	NULL
the	NULL
transgenic	NULL
T	NULL
cells	NULL
was	NULL
essentially	NULL
the	NULL
same	NULL
as	NULL
the	NULL
negative	NULL
littermate	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
7F	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
elevation	NULL
of	NULL
JunB	NULL
levels	NULL
to	NULL
that	NULL
of	NULL
Th2	NULL
cells	NULL
is	NULL
sufficient	NULL
to	NULL
direct	NULL
the	NULL
synthesis	NULL
of	NULL
Th2	NULL
cytokines	NULL
in	NULL
Th1	NULL
cell	NULL
populations	NULL
.	NULL

Discussion	NULL
The	NULL
molecular	NULL
basis	NULL
for	NULL
T-helper-restricted	NULL
expression	NULL
of	NULL
cytokines	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

IL-4	NULL
is	NULL
the	NULL
key	NULL
cytokine	NULL
that	NULL
determines	NULL
the	NULL
Th2-differentiation	NULL
pathway	NULL
.	NULL

Recently	NULL
,	NULL
c-Maf	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
GATA-3	NULL
(	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
selectively	NULL
expressed	NULL
in	NULL
Th2	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

Both	NULL
factors	NULL
are	NULL
able	NULL
to	NULL
induce	NULL
IL-4	NULL
gene	NULL
expression	NULL
in	NULL
populations	NULL
that	NULL
normally	NULL
do	NULL
not	NULL
express	NULL
this	NULL
gene	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
GATA-3	NULL
has	NULL
a	NULL
profound	NULL
global	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
most	NULL
Th2	NULL
cytokines	NULL
.	NULL

While	NULL
it	NULL
is	NULL
at	NULL
present	NULL
unclear	NULL
how	NULL
GATA-3	NULL
acts	NULL
,	NULL
either	NULL
locally	NULL
at	NULL
cytokine	NULL
promoters	NULL
or	NULL
globally	NULL
at	NULL
the	NULL
Th2	NULL
locus	NULL
or	NULL
both	NULL
,	NULL
c-Maf	NULL
directly	NULL
binds	NULL
and	NULL
activates	NULL
the	NULL
IL-4	NULL
gene	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
how	NULL
c-Maf	NULL
plays	NULL
its	NULL
role	NULL
in	NULL
Th2	NULL
differentiation	NULL
since	NULL
by	NULL
the	NULL
time	NULL
c-Maf	NULL
upregulation	NULL
is	NULL
manifested	NULL
at	NULL
day	NULL
8	NULL
after	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
Th2	NULL
differentiation	NULL
has	NULL
been	NULL
completed	NULL
for	NULL
several	NULL
days	NULL
.	NULL

Our	NULL
studies	NULL
(	NULL
Rincon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
this	NULL
report	NULL
)	NULL
show	NULL
that	NULL
a	NULL
third	NULL
transcription	NULL
factor	NULL
,	NULL
JunB	NULL
,	NULL
is	NULL
selectively	NULL
expressed	NULL
in	NULL
developing	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Thl	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
now	NULL
demonstrate	NULL
that	NULL
JunB	NULL
plays	NULL
a	NULL
causal	NULL
role	NULL
in	NULL
this	NULL
process	NULL
since	NULL
JunB	NULL
overexpression	NULL
in	NULL
transgenic	NULL
mice	NULL
upregulated	NULL
all	NULL
Th2	NULL
cytokines	NULL
assayed	NULL
.	NULL

We	NULL
further	NULL
demonstrate	NULL
that	NULL
JunB	NULL
and	NULL
c-Maf	NULL
activate	NULL
IL-4	NULL
expression	NULL
synergistically	NULL
.	NULL

The	NULL
early	NULL
upregulation	NULL
of	NULL
JunB	NULL
in	NULL
Th2	NULL
cells	NULL
could	NULL
provide	NULL
the	NULL
tissue	NULL
specificity	NULL
for	NULL
c-Maf	NULL
during	NULL
Th2	NULL
differentiation	NULL
while	NULL
the	NULL
accumulation	NULL
of	NULL
large	NULL
amounts	NULL
of	NULL
c-Maf	NULL
later	NULL
might	NULL
serve	NULL
to	NULL
maintain	NULL
a	NULL
high	NULL
level	NULL
of	NULL
IL-4	NULL
.	NULL

Previous	NULL
studies	NULL
of	NULL
the	NULL
role	NULL
of	NULL
AP-1	NULL
in	NULL
T	NULL
helper	NULL
cell	NULL
development	NULL
have	NULL
generated	NULL
somewhat	NULL
inconsistent	NULL
results	NULL
.	NULL

First	NULL
,	NULL
different	NULL
observations	NULL
were	NULL
made	NULL
as	NULL
to	NULL
whether	NULL
AP-1	NULL
complexes	NULL
are	NULL
differentially	NULL
accumulated	NULL
in	NULL
Thl	NULL
versus	NULL
Th2	NULL
cells	NULL
.	NULL

In	NULL
gel-shift	NULL
experiments	NULL
using	NULL
extracts	NULL
from	NULL
long-term	NULL
Thl	NULL
and	NULL
Th2	NULL
clones	NULL
AE7	NULL
and	NULL
D1QO	NULL
,	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
found	NULL
that	NULL
AP-1	NULL
complexes	NULL
from	NULL
both	NULL
AE7	NULL
and	NULL
D10	NULL
cells	NULL
were	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
P1	NULL
element	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
and	NULL
that	NULL
JunB	NULL
was	NULL
present	NULL
in	NULL
both	NULL
of	NULL
the	NULL
complexes	NULL
that	NULL
were	NULL
detected	NULL
by	NULL
EMSA	NULL
.	NULL

However	NULL
,	NULL
in	NULL
another	NULL
study	NULL
using	NULL
primary	NULL
T	NULL
cells	NULL
(	NULL
Wenner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
the	NULL
AP-1-containing	NULL
complex	NULL
which	NULL
shows	NULL
a	NULL
lower	NULL
mobility	NULL
in	NULL
the	NULL
gel-shift	NULL
assay	NULL
was	NULL
only	NULL
observed	NULL
using	NULL
activated	NULL
Th2	NULL
extracts	NULL
.	NULL

A	NULL
parallel	NULL
study	NULL
(	NULL
Rincon	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
also	NULL
found	NULL
accumulated	NULL
AP-1	NULL
complexes	NULL
with	NULL
some	NULL
c-Fos	NULL
,	NULL
and	NULL
high	NULL
levels	NULL
of	NULL
JunB-containing	NULL
complexes	NULL
in	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
was	NULL
also	NULL
enhanced	NULL
in	NULL
Th2	NULL
cells	NULL
relative	NULL
to	NULL
Th1	NULL
cells	NULL
.	NULL

Secondly	NULL
,	NULL
different	NULL
conclusions	NULL
have	NULL
been	NULL
made	NULL
as	NULL
to	NULL
whether	NULL
AP-1	NULL
contributes	NULL
to	NULL
Th2-specific	NULL
IL-4	NULL
expression	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
the	NULL
NFAT/	NULL
AP-1	NULL
sites	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
were	NULL
functionally	NULL
interchangeable	NULL
in	NULL
AE7	NULL
and	NULL
D10	NULL
cells	NULL
(	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
led	NULL
to	NULL
the	NULL
proposal	NULL
that	NULL
AP-1	NULL
does	NULL
not	NULL
determine	NULL
Th1/Th2	NULL
specificity	NULL
.	NULL

However	NULL
,	NULL
in	NULL
transgenic	NULL
mice	NULL
,	NULL
multimerization	NULL
of	NULL
the	NULL
same	NULL
NFAT/AP-1	NULL
site	NULL
was	NULL
found	NULL
to	NULL
direct	NULL
luciferase	NULL
reporter	NULL
gene	NULL
expression	NULL
only	NULL
in	NULL
Th2	NULL
cells	NULL
(	NULL
Wenner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
as	NULL
was	NULL
the	NULL
expression	NULL
of	NULL
similar	NULL
AP-1	NULL
and	NULL
NFAT/AP-1	NULL
sites	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Rincon	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
;	NULL
Rincon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
discrepancies	NULL
could	NULL
simply	NULL
represent	NULL
the	NULL
different	NULL
behaviors	NULL
of	NULL
long-term	NULL
T	NULL
cell	NULL
clones	NULL
and	NULL
primary	NULL
cells	NULL
,	NULL
or	NULL
alternatively	NULL
,	NULL
differences	NULL
in	NULL
experimental	NULL
systems	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
promoter	NULL
activity	NULL
during	NULL
the	NULL
process	NULL
of	NULL
Th1/	NULL
Th2	NULL
differentiation	NULL
not	NULL
only	NULL
provides	NULL
a	NULL
normal	NULL
cellular	NULL
context	NULL
,	NULL
but	NULL
also	NULL
addresses	NULL
developmental	NULL
requirements	NULL
and	NULL
we	NULL
have	NULL
therefore	NULL
used	NULL
this	NULL
approach	NULL
(	NULL
Rincon	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
;	NULL
Rincon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
this	NULL
study	NULL
)	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
JunB	NULL
is	NULL
specifically	NULL
induced	NULL
in	NULL
developing	NULL
Th2	NULL
cells	NULL
provides	NULL
a	NULL
molecular	NULL
explanation	NULL
for	NULL
the	NULL
observation	NULL
that	NULL
P1	NULL
NFAT/AP-1	NULL
elements	NULL
drive	NULL
Th2-restricted	NULL
expression	NULL
.	NULL

Several	NULL
mechanisms	NULL
assure	NULL
the	NULL
specificity	NULL
of	NULL
IL-4	NULL
gene	NULL
activation	NULL
by	NULL
JunB	NULL
.	NULL

First	NULL
,	NULL
the	NULL
differential	NULL
induction	NULL
of	NULL
JunB	NULL
was	NULL
not	NULL
observed	NULL
for	NULL
either	NULL
c-Jun	NULL
or	NULL
JunD	NULL
.	NULL

Thus	NULL
,	NULL
JunB	NULL
is	NULL
the	NULL
only	NULL
Jun	NULL
family	NULL
member	NULL
that	NULL
is	NULL
differentially	NULL
regulated	NULL
and	NULL
has	NULL
the	NULL
potential	NULL
to	NULL
contribute	NULL
to	NULL
Th-specific	NULL
gene	NULL
expression	NULL
.	NULL

Secondly	NULL
,	NULL
among	NULL
the	NULL
Jun	NULL
family	NULL
members	NULL
,	NULL
only	NULL
JunB	NULL
is	NULL
capable	NULL
of	NULL
synergizing	NULL
with	NULL
c-Maf	NULL
to	NULL
activate	NULL
the	NULL
IL-4	NULL
gene	NULL
.	NULL

As	NULL
shown	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
c-Jun	NULL
is	NULL
present	NULL
in	NULL
both	NULL
Th1l	NULL
and	NULL
Th2	NULL
cells	NULL
,	NULL
and	NULL
c-Jun	NULL
alone	NULL
possesses	NULL
an	NULL
ability	NULL
to	NULL
activate	NULL
the	NULL
IL-4	NULL
promoter	NULL
that	NULL
is	NULL
similar	NULL
to	NULL
JunB	NULL
.	NULL

However	NULL
,	NULL
the	NULL
synergy	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
generates	NULL
much	NULL
higher	NULL
IL-4	NULL
promoter	NULL
activity	NULL
,	NULL
while	NULL
c-Jun	NULL
can	NULL
only	NULL
generate	NULL
at	NULL
most	NULL
low	NULL
level	NULL
activity	NULL
in	NULL
this	NULL
context	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
JunB	NULL
was	NULL
found	NULL
to	NULL
inhibit	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
could	NULL
provide	NULL
another	NULL
mechanism	NULL
for	NULL
this	NULL
specificity	NULL
(	NULL
Chiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Schutte	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
was	NULL
proposed	NULL
that	NULL
JunB	NULL
might	NULL
form	NULL
heterodimers	NULL
with	NULL
c-Jun	NULL
and	NULL
thus	NULL
attenuate	NULL
the	NULL
formation	NULL
of	NULL
c-Jun	NULL
homodimers	NULL
,	NULL
the	NULL
mechanism	NULL
for	NULL
JunB	NULL
inhibition	NULL
of	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

Our	NULL
discovery	NULL
that	NULL
JunB	NULL
is	NULL
an	NULL
excellent	NULL
substrate	NULL
for	NULL
JNK	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
in	NULL
those	NULL
experiments	NULL
overexpressed	NULL
JunB	NULL
might	NULL
have	NULL
competed	NULL
with	NULL
c-Jun	NULL
for	NULL
JNK	NULL
binding	NULL
and	NULL
thus	NULL
led	NULL
to	NULL
reduced	NULL
c-Jun	NULL
phosphorylation	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
JunB	NULL
has	NULL
a	NULL
much	NULL
lower	NULL
activity	NULL
than	NULL
c-Jun	NULL
in	NULL
driving	NULL
transcription	NULL
of	NULL
a	NULL
TRE-luciferase	NULL
reporter	NULL
and	NULL
its	NULL
apparent	NULL
inhibitory	NULL
effect	NULL
on	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
(	NULL
Chiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Schutte	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
has	NULL
loosely	NULL
classified	NULL
JunB	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

However	NULL
,	NULL
our	NULL
study	NULL
has	NULL
clearly	NULL
shown	NULL
that	NULL
JunB	NULL
directly	NULL
binds	NULL
the	NULL
IL-4	NULL
promoter	NULL
and	NULL
activates	NULL
its	NULL
transcription	NULL
.	NULL

Interestingly	NULL
,	NULL
JunB	NULL
does	NULL
not	NULL
activate	NULL
two	NULL
other	NULL
constructs	NULL
containing	NULL
AP-1	NULL
binding	NULL
sites	NULL
,	NULL
while	NULL
c-Jun	NULL
does	NULL
.	NULL

Thus	NULL
,	NULL
JunB	NULL
differs	NULL
in	NULL
its	NULL
promoter	NULL
selectivity	NULL
from	NULL
c-Jun	NULL
and	NULL
activates	NULL
or	NULL
inhibits	NULL
transcription	NULL
within	NULL
a	NULL
specific	NULL
promoter	NULL
context	NULL
.	NULL

A	NULL
striking	NULL
finding	NULL
of	NULL
our	NULL
current	NULL
study	NULL
is	NULL
the	NULL
role	NULL
of	NULL
phosphorylation	NULL
on	NULL
JunB	NULL
function	NULL
in	NULL
T	NULL
helper	NULL
cells	NULL
.	NULL

Previously	NULL
JunB	NULL
had	NULL
not	NULL
been	NULL
thought	NULL
to	NULL
be	NULL
a	NULL
phosphorylation	NULL
substrate	NULL
for	NULL
JNK	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
this	NULL
molecule	NULL
has	NULL
a	NULL
conserved	NULL
JNK	NULL
binding	NULL
site	NULL
(	NULL
Gupta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Kallunki	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
found	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
synergy	NULL
of	NULL
JunB	NULL
with	NULL
c-Maf	NULL
was	NULL
strongly	NULL
potentiated	NULL
by	NULL
stimulation	NULL
of	NULL
M12	NULL
cells	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Furthermore	NULL
,	NULL
direct	NULL
studies	NULL
of	NULL
JunB	NULL
phosphorylation	NULL
showed	NULL
that	NULL
two	NULL
threonine	NULL
residues	NULL
flanked	NULL
by	NULL
prolines	NULL
(	NULL
Thr1l02	NULL
and	NULL
JunB	NULL
regulates	NULL
Th2	NULL
differentiation	NULL
Thr104	NULL
)	NULL
were	NULL
phosphorylated	NULL
equally	NULL
efficiently	NULL
as	NULL
the	NULL
prototypic	NULL
JNK	NULL
phosphorylation	NULL
sites	NULL
at	NULL
Ser63	NULL
and	NULL
Ser73	NULL
of	NULL
c-Jun	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

The	NULL
JunB	NULL
phosphorylation	NULL
sites	NULL
are	NULL
similar	NULL
to	NULL
the	NULL
phosphorylation	NULL
sites	NULL
on	NULL
ATF-2	NULL
,	NULL
also	NULL
recognized	NULL
by	NULL
JNK	NULL
(	NULL
Gupta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
removal	NULL
of	NULL
these	NULL
phosphorylation	NULL
sites	NULL
by	NULL
replacement	NULL
of	NULL
both	NULL
Thr	NULL
residues	NULL
with	NULL
Ala	NULL
,	NULL
abolished	NULL
phosphorylation	NULL
and	NULL
reduced	NULL
the	NULL
transcriptional	NULL
synergy	NULL
with	NULL
c-Maf	NULL
.	NULL

Conversely	NULL
,	NULL
replacement	NULL
of	NULL
these	NULL
Thr	NULL
residues	NULL
with	NULL
Glu	NULL
,	NULL
mimicking	NULL
constitutive	NULL
phosphorylation	NULL
at	NULL
these	NULL
sites	NULL
,	NULL
gave	NULL
stronger	NULL
synergy	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulation	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
than	NULL
was	NULL
observed	NULL
with	NULL
wild-type	NULL
or	NULL
Ala	NULL
mutants	NULL
(	NULL
Figure	NULL
4C	NULL
)	NULL
.	NULL

The	NULL
initial	NULL
observation	NULL
of	NULL
transcriptional	NULL
synergy	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
they	NULL
are	NULL
both	NULL
b-Zip	NULL
proteins	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
they	NULL
might	NULL
form	NULL
heterodimers	NULL
(	NULL
Kerppola	NULL
and	NULL
Curran	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
found	NULL
that	NULL
JunB	NULL
directly	NULL
interacts	NULL
with	NULL
c-Maf	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
could	NULL
not	NULL
identify	NULL
a	NULL
DNA	NULL
element	NULL
that	NULL
binds	NULL
JunB	NULL
within	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
c-Maf	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
the	NULL
P1	NULL
element	NULL
as	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
JunB	NULL
indicated	NULL
that	NULL
JunB	NULL
and	NULL
c-Maf	NULL
probably	NULL
bind	NULL
to	NULL
independent	NULL
sites	NULL
,	NULL
possibly	NULL
as	NULL
homodimers	NULL
.	NULL

The	NULL
DNA-binding	NULL
experiment	NULL
using	NULL
c-Maf	NULL
beads	NULL
suggests	NULL
that	NULL
JunB	NULL
and	NULL
c-Maf	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
,	NULL
directly	NULL
or	NULL
indirectly	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
enhanced	NULL
by	NULL
JunB	NULL
phosphorylation	NULL
,	NULL
which	NULL
also	NULL
contributed	NULL
significantly	NULL
to	NULL
the	NULL
transcriptional	NULL
synergy	NULL
between	NULL
JunB	NULL
and	NULL
c-Maf	NULL
suggesting	NULL
that	NULL
this	NULL
interaction	NULL
mediates	NULL
this	NULL
synergy	NULL
.	NULL

The	NULL
potentiation	NULL
of	NULL
c-Maf	NULL
DNA	NULL
binding	NULL
by	NULL
JunB	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
JunB	NULL
by	NULL
JNK	NULL
at	NULL
Thr102	NULL
and	NULL
Thr1Q04	NULL
.	NULL

This	NULL
may	NULL
explain	NULL
why	NULL
c-Jun	NULL
only	NULL
poorly	NULL
mediates	NULL
this	NULL
interaction	NULL
and	NULL
therefore	NULL
does	NULL
not	NULL
synergize	NULL
with	NULL
c-Maf	NULL
to	NULL
drive	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
IL-4	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
c-Jun	NULL
is	NULL
strongly	NULL
phosphorylated	NULL
at	NULL
Ser63	NULL
and	NULL
Ser73	NULL
,	NULL
and	NULL
is	NULL
only	NULL
poorly	NULL
phosphorylated	NULL
by	NULL
JNK	NULL
on	NULL
other	NULL
sites	NULL
.	NULL

Similar	NULL
to	NULL
our	NULL
previous	NULL
findings	NULL
with	NULL
GATA-3	NULL
,	NULL
JunB	NULL
stimulates	NULL
expression	NULL
of	NULL
multiple	NULL
Th2	NULL
cytokine	NULL
genes	NULL
.	NULL

JunB	NULL
strongly	NULL
actives	NULL
IL-4	NULL
and	NULL
IL-5	NULL
,	NULL
and	NULL
modestly	NULL
activates	NULL
IL-6	NULL
and	NULL
IL-10	NULL
expression	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
whereas	NULL
GATA-3	NULL
strongly	NULL
increased	NULL
IL-4	NULL
,	NULL
IL-6	NULL
and	NULL
IL-10	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
IL-5	NULL
.	NULL

JunB	NULL
could	NULL
induce	NULL
IL-4	NULL
expression	NULL
directly	NULL
and	NULL
increase	NULL
the	NULL
expression	NULL
of	NULL
other	NULL
cytokines	NULL
indirectly	NULL
through	NULL
the	NULL
effect	NULL
on	NULL
IL-4	NULL
.	NULL

However	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
little	NULL
IL-4	NULL
was	NULL
present	NULL
in	NULL
the	NULL
Th1	NULL
culture	NULL
due	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
IL-4	NULL
antibody	NULL
argues	NULL
against	NULL
the	NULL
latter	NULL
scenario	NULL
.	NULL

Alternatively	NULL
,	NULL
JunB	NULL
could	NULL
directly	NULL
activate	NULL
each	NULL
cytokine	NULL
gene	NULL
.	NULL

JunB	NULL
emerges	NULL
as	NULL
a	NULL
new	NULL
Th2-specific	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
Th2-restricted	NULL
cytokine	NULL
expression	NULL
.	NULL

It	NULL
would	NULL
be	NULL
interesting	NULL
to	NULL
further	NULL
dissect	NULL
in	NULL
future	NULL
experiments	NULL
the	NULL
immediate	NULL
early	NULL
events	NULL
that	NULL
lead	NULL
to	NULL
upregulation	NULL
of	NULL
JunB	NULL
in	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Thl	NULL
cells	NULL
,	NULL
which	NULL
ultimately	NULL
influences	NULL
the	NULL
fate	NULL
of	NULL
Th1/Th2	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Plasmid	NULL
constructs	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
The	NULL
IL-4-luciferase	NULL
reporter	NULL
plasmid	NULL
pIL4-157luc	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vectors	NULL
c-Jun/	NULL
pMexNeo	NULL
,	NULL
JunD/pMexNeo	NULL
and	NULL
JunB/pMexNeo	NULL
II	NULL
were	NULL
kind	NULL
gifts	NULL
of	NULL
Dr	NULL
R.Bravo	NULL
.	NULL

pREPA4/NFATe	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr	NULL
L.Glimcher	NULL
.	NULL

pSH210	NULL
(	NULL
expression	NULL
vector	NULL
for	NULL
human	NULL
NFATcZ/NFATp	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
G.Crabtree	NULL
.	NULL

pSKMSV/EBPB	NULL
(	NULL
expression	NULL
vector	NULL
for	NULL
C/EBPB	NULL
)	NULL
was	NULL
429	NULL
B.Li	NULL
et	NULL
al	NULL
.	NULL

kindly	NULL
provided	NULL
by	NULL
Dr	NULL
S.McKnight	NULL
.	NULL

Bacterial	NULL
expression	NULL
of	NULL
GST-Jun	NULL
(	NULL
Dérijard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
GST-ATF2	NULL
(	NULL
Gupta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
GST-Myc	NULL
(	NULL
Alvarez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

The	NULL
mammalian	NULL
and	NULL
the	NULL
bacterial	NULL
expression	NULL
vectors	NULL
for	NULL
wild-type	NULL
and	NULL
mutants	NULL
JunB	NULL
were	NULL
constructed	NULL
by	NULL
subcloning	NULL
the	NULL
JunB	NULL
full-length	NULL
DNA	NULL
into	NULL
pCDNA3	NULL
(	NULL
Invitrogen	NULL
)	NULL
and	NULL
a	NULL
PCR	NULL
fragment	NULL
corresponding	NULL
to	NULL
residues	NULL
1-248	NULL
of	NULL
JunB	NULL
into	NULL
pGEX-5X1	NULL
(	NULL
Pharmacia-LKB	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
Flag	NULL
epitope	NULL
(	NULL
-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-	NULL
;	NULL
Immunex	NULL
Corp.	NULL
)	NULL
was	NULL
inserted	NULL
between	NULL
codons	NULL
1	NULL
and	NULL
2	NULL
by	NULL
insertional	NULL
overlapping	NULL
PCR	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

To	NULL
replace	NULL
Thr102	NULL
and	NULL
Thr104	NULL
with	NULL
Ala	NULL
or	NULL
Glu	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
was	NULL
performed	NULL
with	NULL
overlap	NULL
extension	NULL
by	NULL
PCR	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
the	NULL
expression	NULL
vectors	NULL
was	NULL
confirmed	NULL
by	NULL
automated	NULL
sequencing	NULL
using	NULL
a	NULL
model	NULL
373A	NULL
machine	NULL
(	NULL
Applied	NULL
Biosystems	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
by	NULL
glutathione	NULL
affinity	NULL
chromatography	NULL
(	NULL
Smith	NULL
and	NULL
Johnson	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
IL-4	NULL
luciferase	NULL
constructs	NULL
with	NULL
AP-1	NULL
or	NULL
MARE	NULL
sites	NULL
mutated	NULL
were	NULL
generated	NULL
using	NULL
Quick	NULL
Change	NULL
Kit	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
were	NULL
:	NULL
CCAGAATAACTGACAATCTGGCTGCAGAAAATTTTCCAA-TGTAAACTC	NULL
and	NULL
GAGTTTACATTGGAAAATTTTCTGCAGCCA-GATTGTCAGTTATTCTGG	NULL
for	NULL
the	NULL
AP-1	NULL
site	NULL
mutation	NULL
;	NULL
CTCATTTT-CCCTTGGTTTCGAATTCTTTAACTCTATATATAGAGAG	NULL
and	NULL
CTCT-CTATATATAGAGTTAAAGAATTCGAAACCAAGGGAAAATGAG	NULL
for	NULL
the	NULL
MARE	NULL
site	NULL
mutation	NULL
.	NULL

In	NULL
vitro	NULL
differentiation	NULL
of	NULL
CD4	NULL
T	NULL
cells	NULL
Naive	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
transgenic	NULL
mice	NULL
or	NULL
wild-type	NULL
littermates	NULL
using	NULL
methods	NULL
described	NULL
previously	NULL
(	NULL
Kamogawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
APC	NULL
has	NULL
also	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Kamogawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

To	NULL
differentiate	NULL
CD4	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
,	NULL
naive	NULL
T	NULL
cells	NULL
(	NULL
1x10	NULL
ml	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
an	NULL
equal	NULL
number	NULL
of	NULL
APC	NULL
,	NULL
2.5	NULL
mg/ml	NULL
Con	NULL
A	NULL
and	NULL
30	NULL
U/ml	NULL
IL-2	NULL
in	NULL
Bruff	NULL
's	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

For	NULL
Th1	NULL
differentiation	NULL
,	NULL
IL-12	NULL
(	NULL
3.5	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
the	NULL
anti-IL-4	NULL
monoclonal	NULL
antibody	NULL
11B11	NULL
were	NULL
added	NULL
;	NULL
for	NULL
Th2	NULL
differentiation	NULL
,	NULL
IL-4	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
and	NULL
the	NULL
IFN-y	NULL
monoclonal	NULL
antibody	NULL
XMG1.2	NULL
were	NULL
added	NULL
.	NULL

For	NULL
re-stimulation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
4	NULL
days	NULL
after	NULL
stimulation	NULL
,	NULL
washed	NULL
and	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
Bruff	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
2.5	NULL
ug/ml	NULL
Con	NULL
A.	NULL
Transgenic	NULL
mice	NULL
The	NULL
JunB	NULL
cDNA	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
Sell	NULL
site	NULL
of	NULL
the	NULL
CD4	NULL
promoter/	NULL
enhancer	NULL
plasmid	NULL
p37.1	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
D.Littman	NULL
)	NULL
,	NULL
which	NULL
expresses	NULL
in	NULL
both	NULL
CD4	NULL
and	NULL
CD8	NULL
cells	NULL
.	NULL

A	NULL
Nof	NULL
fragment	NULL
of	NULL
this	NULL
plasmid	NULL
was	NULL
isolated	NULL
and	NULL
injected	NULL
into	NULL
fertilized	NULL
eggs	NULL
of	NULL
(	NULL
B6XC3HDF	NULL
;	NULL
,	NULL
and	NULL
transgenic	NULL
mice	NULL
were	NULL
generated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Hogan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Founders	NULL
were	NULL
screened	NULL
with	NULL
primer	NULL
CD4seq2	NULL
derived	NULL
from	NULL
the	NULL
CD4	NULL
second	NULL
exon	NULL
and	NULL
primer	NULL
JunBrl	NULL
derived	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
JunB	NULL
cDNA	NULL
.	NULL

Positive	NULL
founders	NULL
were	NULL
confirmed	NULL
by	NULL
Southern	NULL
blotting	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
was	NULL
checked	NULL
with	NULL
RT-PCR	NULL
on	NULL
peripheral	NULL
lymphocytes	NULL
using	NULL
primer	NULL
CD4seql	NULL
derived	NULL
from	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
CD4	NULL
gene	NULL
and	NULL
the	NULL
JunBr1	NULL
.	NULL

Founders	NULL
were	NULL
bred	NULL
with	NULL
B6	NULL
mice	NULL
and	NULL
the	NULL
F	NULL
;	NULL
mice	NULL
were	NULL
used	NULL
for	NULL
experiments	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
primers	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
JunBrl	NULL
,	NULL
5'-GTGGGTTTCAGGAGTTTGTAGTCG-3	NULL
'	NULL
;	NULL
CD4seq2	NULL
,	NULL
5'-GCTCA-GATTCCCAACCAACAAGAG-3	NULL
'	NULL
;	NULL
CD4seql	NULL
,	NULL
5'-GTGAAGGAAGG-ACTGGCCAGAG-3	NULL
'	NULL
.	NULL

RT-PCR	NULL
Total	NULL
RNA	NULL
was	NULL
prepared	NULL
using	NULL
Trizol	NULL
from	NULL
Gibco-BRL	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Reverse	NULL
transcription	NULL
was	NULL
done	NULL
using	NULL
Superscript	NULL
II	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
cytokines	NULL
and	NULL
PCR	NULL
conditions	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
Reiner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
B-tubulin	NULL
are	NULL
5-TGTCCATGAAGGAGGTGG-ATGAG-3	NULL
'	NULL
and	NULL
5'-ATGTTGCTCTCAGCCTCGGTGAAC-3	NULL
'	NULL
.	NULL

Immunization	NULL
Mice	NULL
were	NULL
immunized	NULL
with	NULL
50	NULL
jug	NULL
KLH	NULL
in	NULL
complete	NULL
Freund	NULL
's	NULL
adjuvant	NULL
(	NULL
CFA	NULL
)	NULL
in	NULL
each	NULL
hind	NULL
footpad	NULL
.	NULL

CD4	NULL
T	NULL
cells	NULL
in	NULL
draining	NULL
lymph	NULL
nodes	NULL
were	NULL
isolated	NULL
9	NULL
days	NULL
later	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Kamogawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
2X10°	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
APC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
KLH	NULL
.	NULL

After	NULL
4	NULL
days	NULL
,	NULL
supernatant	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
was	NULL
assayed	NULL
using	NULL
an	NULL
ELISA	NULL
kit	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
PharMingen	NULL
)	NULL
.	NULL

For	NULL
proliferation	NULL
assays	NULL
,	NULL
1	NULL
Ci	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
18	NULL
h	NULL
and	NULL
the	NULL
radioactivity	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
B-counter	NULL
(	NULL
Beckman	NULL
)	NULL
.	NULL

Triplicates	NULL
of	NULL
each	NULL
sample	NULL
were	NULL
measured	NULL
and	NULL
average	NULL
values	NULL
determined	NULL
.	NULL

EMSA	NULL
Naive	NULL
T	NULL
cells	NULL
were	NULL
differentiated	NULL
to	NULL
Th2	NULL
in	NULL
vitro	NULL
for	NULL
3	NULL
days	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
for	NULL
2	NULL
h	NULL
and	NULL
430	NULL
nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Tugores	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Complementary	NULL
oligo	NULL
nucleotides	NULL
containing	NULL
P1	NULL
element	NULL
(	NULL
5'-GACAATCTGGTGTAATAAAATTTTCCAATG-3	NULL
'	NULL
and	NULL
its	NULL
complementary	NULL
strand	NULL
)	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
°°P	NULL
]	NULL
ATP	NULL
(	NULL
ICN	NULL
)	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
NEB	NULL
)	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
purified	NULL
using	NULL
a	NULL
G50	NULL
Sepharose	NULL
column	NULL
.	NULL

Radiolabeled	NULL
probe	NULL
(	NULL
210+	NULL
c.p.m	NULL
.	NULL
)	NULL

was	NULL
incubated	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
buffer	NULL
10	NULL
mM	NULL
HEPES	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
8	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
together	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
4	NULL
pug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

In	NULL
the	NULL
supershift	NULL
experiments	NULL
,	NULL
JunB	NULL
and	NULL
c-Jun	NULL
polyclonal	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
were	NULL
pre-incubated	NULL
with	NULL
extract	NULL
for	NULL
20	NULL
min	NULL
before	NULL
adding	NULL
probe	NULL
.	NULL

The	NULL
total	NULL
volume	NULL
for	NULL
the	NULL
binding	NULL
reaction	NULL
is	NULL
20	NULL
pil	NULL
,	NULL
of	NULL
which	NULL
,	NULL
15	NULL
pul	NULL
was	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
with	NULL
0.5	NULL
%	NULL
TBE	NULL
and	NULL
run	NULL
at	NULL
16	NULL
mA	NULL
at	NULL
4°C	NULL
for	NULL
2.5	NULL
h.	NULL
Western	NULL
blot	NULL
analysis	NULL
Nuclear	NULL
extract	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
was	NULL
run	NULL
on	NULL
a	NULL
precast	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
(	NULL
Novex	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
Immobilon-p	NULL
transfer	NULL
membrane	NULL
(	NULL
Millipore	NULL
)	NULL
with	NULL
a	NULL
semi-dry	NULL
transfer	NULL
unit	NULL
(	NULL
Hoefer	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
blotted	NULL
with	NULL
polyclonal	NULL
JunB	NULL
,	NULL
c-Jun	NULL
,	NULL
JunD	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
or	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
the	NULL
Flag	NULL
epitope	NULL
(	NULL
Kodak	NULL
)	NULL
and	NULL
processed	NULL
using	NULL
the	NULL
ECL	NULL
Western	NULL
blot	NULL
reagents	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

A	NULL
polyclonal	NULL
antibody	NULL
against	NULL
actin	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
loading	NULL
.	NULL

Tissue	NULL
culture	NULL
and	NULL
transfection	NULL
assays	NULL
COS-7	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
37°C	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
and	NULL
100	NULL
U/ml	NULL
!	NULL

streptomycin	NULL
in	NULL
a	NULL
humidified	NULL
environment	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Transient	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
LipofectAMINE	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommenda-tions	NULL
.	NULL

After	NULL
36	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
serum-starved	NULL
overnight	NULL
and	NULL
treated	NULL
with	NULL
UV-C	NULL
(	NULL
80	NULL
J/m	NULL
)	NULL
,	NULL
or	NULL
TPA	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
60	NULL
and	NULL
15	NULL
min	NULL
,	NULL
respectively	NULL
,	NULL
prior	NULL
to	NULL
lysis	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.137	NULL
M	NULL
NaCl	NULL
,	NULL
25	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
]	NULL
and	NULL
centrifuged	NULL
at	NULL
915	NULL
000	NULL
g	NULL
(	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
)	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
total	NULL
soluble	NULL
protein	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
quantitated	NULL
using	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
lymphoma	NULL
M12	NULL
was	NULL
cultured	NULL
in	NULL
Bruff	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FBS	NULL
.	NULL

The	NULL
transfection	NULL
of	NULL
M12	NULL
cells	NULL
was	NULL
done	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Protein	NULL
kinase	NULL
assays	NULL
Epitope-tagged	NULL
MAPKs	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
cell	NULL
extracts	NULL
by	NULL
incubation	NULL
for	NULL
3	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
the	NULL
M2	NULL
monoclonal	NULL
antibody	NULL
to	NULL
Flag	NULL
(	NULL
IBI-Kodak	NULL
)	NULL
or	NULL
12CA5	NULL
monoclonal	NULL
antibody	NULL
to	NULL
HA	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
bound	NULL
to	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia-LKB	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Endogenous	NULL
JNK	NULL
,	NULL
p38	NULL
MAPK	NULL
and	NULL
ERK	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
polyclonal	NULL
antibodies	NULL
pre-bound	NULL
to	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia-LKB	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
three	NULL
times	NULL
with	NULL
the	NULL
kinase	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
HEPES	NULL
pH	NULL
7.4	NULL
,	NULL
25	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
25	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
)	NULL
.	NULL

The	NULL
MAPK	NULL
activity	NULL
was	NULL
measured	NULL
at	NULL
30°C	NULL
for	NULL
20	NULL
min	NULL
in	NULL
30	NULL
pil	NULL
of	NULL
kinase	NULL
buffer	NULL
containing	NULL
1	NULL
ug	NULL
of	NULL
recombinant	NULL
GST-Jun	NULL
,	NULL
GST-JunB	NULL
,	NULL
GST-ATF2	NULL
or	NULL
GST-Mye	NULL
and	NULL
50	NULL
uM	NULL
[	NULL
y°P	NULL
]	NULL
JATP	NULL
(	NULL
10	NULL
Ci/mmol	NULL
,	NULL
1	NULL
Ci	NULL
=	NULL
37.6	NULL
Gbg	NULL
)	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
terminated	NULL
by	NULL
addition	NULL
of	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
.	NULL

Proteins	NULL
were	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
identified	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
incorporation	NULL
of	NULL
[	NULL
°°PJphosphate	NULL
into	NULL
the	NULL
GST	NULL
fusion	NULL
protein	NULL
was	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

Phosphoamino	NULL
acid	NULL
analysis	NULL
Phosphoamino	NULL
acid	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
partial	NULL
acid	NULL
hydrolysis	NULL
(	NULL
1	NULL
h	NULL
at	NULL
110°C	NULL
in	NULL
6	NULL
M	NULL
HCJ	NULL
)	NULL
and	NULL
thin	NULL
layer	NULL
electrophoresis	NULL
as	NULL
described	NULL
(	NULL
Davis	NULL
and	NULL
Czech	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

Protein	NULL
immobilization	NULL
and	NULL
DNA	NULL
binding	NULL
The	NULL
expression	NULL
vectors	NULL
pET29	NULL
containing	NULL
N-terminal	NULL
(	NULL
amino	NULL
acid	NULL
residues	NULL
1-170	NULL
)	NULL
and	NULL
C-terminal	NULL
(	NULL
amino	NULL
acid	NULL
residues	NULL
171-370	NULL
)	NULL
fragments	NULL
of	NULL
c-Maf	NULL
were	NULL
kind	NULL
gifts	NULL
from	NULL
Dr	NULL
L.Glimcher	NULL
.	NULL

The	NULL
truncated	NULL
c-Maf	NULL
proteins	NULL
were	NULL
expressed	NULL
using	NULL
T7	NULL
polymerase	NULL
in	NULL
the	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
strain	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
induced	NULL
as	NULL
described	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
purified	NULL
using	NULL
the	NULL
S-tag	NULL
purification	NULL
kit	NULL
(	NULL
Novagen	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
immobilized	NULL
on	NULL
the	NULL
beads	NULL
without	NULL
the	NULL
final	NULL
elution	NULL
step	NULL
.	NULL

In	NULL
vitro	NULL
transcription-translation	NULL
was	NULL
done	NULL
using	NULL
the	NULL
Promega	NULL
TNT	NULL
coupled	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
with	NULL
incorporated	NULL
.	NULL

Proteins	NULL
from	NULL
a	NULL
12.5	NULL
ul	NULL
reaction	NULL
were	NULL
used	NULL
as	NULL
input	NULL
to	NULL
assay	NULL
for	NULL
c-Maf	NULL
binding	NULL
.	NULL

The	NULL
reaction	NULL
also	NULL
contains	NULL
20	NULL
ul	NULL
c-Maf	NULL
beads	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
50	NULL
pl	NULL
.	NULL

The	NULL
binding	NULL
buffer	NULL
was	NULL
the	NULL
same	NULL
as	NULL
the	NULL
EMSA	NULL
binding	NULL
buffer	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
mixed	NULL
on	NULL
a	NULL
rotator	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
2	NULL
h	NULL
and	NULL
washed	NULL
with	NULL
binding	NULL
buffer	NULL
three	NULL
times	NULL
.	NULL

Proteins	NULL
immobilized	NULL
on	NULL
the	NULL
beads	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
.	NULL

The	NULL
transcription-translation	NULL
vectors	NULL
JunDpKS*	NULL
,	NULL
JunBpKS*	NULL
and	NULL
c-JunpTZ18R	NULL
were	NULL
kind	NULL
gifts	NULL
of	NULL
Dr	NULL
R.Bravo	NULL
.	NULL

For	NULL
the	NULL
c-Maf-beads	NULL
DNA	NULL
binding	NULL
experiments	NULL
either	NULL
12.5	NULL
ul	NULL
TNT	NULL
product	NULL
or	NULL
100	NULL
ug	NULL
extract	NULL
from	NULL
M12	NULL
cells	NULL
(	NULL
2	NULL
%	NULL
10°	NULL
M12	NULL
cells	NULL
transfected	NULL
with	NULL
20	NULL
ug	NULL
JunB	NULL
,	NULL
JunBala	NULL
,	NULL
JunBglu	NULL
or	NULL
c-Jun	NULL
expression	NULL
vector	NULL
;	NULL
PMA/ionomycin	NULL
was	NULL
added	NULL
1h	NULL
before	NULL
making	NULL
extracts	NULL
)	NULL
,	NULL
40	NULL
pull	NULL
c-Maf	NULL
Beads	NULL
,	NULL
30	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
with	NULL
or	NULL
without	NULL
radiolabeled	NULL
DNA	NULL
fragment	NULL
(	NULL
1	NULL
X10°	NULL
c.p.m	NULL
.	NULL
)	NULL

in	NULL
100	NULL
ul	NULL
total	NULL
volume	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
2	NULL
h	NULL
with	NULL
constant	NULL
mixing	NULL
.	NULL

After	NULL
binding	NULL
,	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
extracted	NULL
with	NULL
phenol	NULL
.	NULL

DNA	NULL
was	NULL
ethanol	NULL
precipitated	NULL
and	NULL
resolved	NULL
on	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Luciferase	NULL
assay	NULL
For	NULL
luciferase	NULL
assays	NULL
,	NULL
4	NULL
ug	NULL
IL-4	NULL
promoter	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
and	NULL
0.8	NULL
ug	NULL
c-Maf	NULL
expression	NULL
plasmids	NULL
were	NULL
used	NULL
.	NULL

For	NULL
all	NULL
other	NULL
expression	NULL
plasmids	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
was	NULL
used	NULL
unless	NULL
otherwise	NULL
noted	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Protein	NULL
concentration	NULL
of	NULL
the	NULL
M12	NULL
extracts	NULL
were	NULL
measured	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
reagent	NULL
.	NULL

Two-hundered	NULL
micrograms	NULL
of	NULL
extract	NULL
was	NULL
used	NULL
to	NULL
assay	NULL
luciferase	NULL
activity	NULL
with	NULL
the	NULL
Promega	NULL
luciferase	NULL
assay	NULL
substrate	NULL
.	NULL

Fifty	NULL
nanograms	NULL
of	NULL
a	NULL
LacZ	NULL
reporter	NULL
plasmid	NULL
was	NULL
co-transfected	NULL
in	NULL
all	NULL
the	NULL
experiments	NULL
.	NULL

Fifty	NULL
micrograms	NULL
of	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
8	NULL
mM	NULL
chlorophenolred-B-p-galactopyranoside	NULL
(	NULL
CPRG	NULL
)	NULL
,	NULL
0.2	NULL
M	NULL
Na	NULL
,	NULL
HPOy4	NULL
pH	NULL
7.3	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
45	NULL
mM	NULL
B-mercaptoethanol	NULL
for	NULL
20	NULL
min	NULL
at	NULL
37°C	NULL
and	NULL
ODs	NULL
;	NULL
,	NULL
readings	NULL
were	NULL
measured	NULL
.	NULL

Acknowledgements	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Dr	NULL
L.Glimcher	NULL
,	NULL
Dr	NULL
R.Bravo	NULL
,	NULL
Dr	NULL
G.Crabtree	NULL
,	NULL
and	NULL
Dr	NULL
S.McKnight	NULL
for	NULL
generously	NULL
providing	NULL
various	NULL
plasmids	NULL
.	NULL

We	NULL
thank	NULL
F.Manzo	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

B.L	NULL
.	NULL

and	NULL
C.T	NULL
.	NULL

are	NULL
associates	NULL
and	NULL
R.A.E	NULL
and	NULL
R.J.D	NULL
.	NULL

are	NULL
investigators	NULL
of	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

R.J.D	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
NIH	NULL
grants	NULL
CA65861	NULL
and	NULL
CA72009	NULL
.	NULL

References	NULL
Abbas	NULL
,	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

and	NULL
Sher	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Functional	NULL
diversity	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
,	NULL
383	NULL
,	NULL
787-793	NULL
.	NULL

Abe	NULL
,	NULL
E.	NULL
,	NULL
De	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
Matsuda	NULL
,	NULL
L.	NULL
,	NULL
Arai	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Arai	NULL
,	NULL
N	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
An	NULL
11-base-pair	NULL
DNA	NULL
sequence	NULL
motif	NULL
apparently	NULL
unique	NULL
to	NULL
the	NULL
human	NULL
interleukin	NULL
4	NULL
gene	NULL
confers	NULL
responsiveness	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
,	NULL
2864-2868	NULL
.	NULL

Alvarez	NULL
,	NULL
E.	NULL
,	NULL
Northwood	NULL
,	NULL
LC	NULL
.	NULL

,	NULL
Gonzalez	NULL
,	NULL
FA	NULL
.	NULL

,	NULL
Latour	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
Seth	NULL
,	NULL
A.	NULL
,	NULL
Abate	NULL
,	NULL
C.	NULL
,	NULL
Curran	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
R.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Pro-Leu-Ser/Thr-Pro	NULL
is	NULL
a	NULL
consensus	NULL
primary	NULL
sequence	NULL
for	NULL
substrate	NULL
protein	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
,	NULL
15277-15285	NULL
.	NULL

Aune	NULL
,	NULL
T.M	NULL
.	NULL

and	NULL
Flavell	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Differential	NULL
expression	NULL
of	NULL
transcription	NULL
directed	NULL
by	NULL
a	NULL
discrete	NULL
NF-AT	NULL
binding	NULL
element	NULL
from	NULL
the	NULL
IL-4	NULL
promoter	NULL
in	NULL
naive	NULL
and	NULL
effector	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
159	NULL
,	NULL
36-43	NULL
.	NULL

Bruhn	NULL
,	NULL
K	NULL
.	NULL

W.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
,	NULL
Boulay	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Paul	NULL
,	NULL
W.E	NULL
.	NULL

and	NULL
Lenardo	NULL
,	NULL
M.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Molecular	NULL
dissection	NULL
of	NULL
the	NULL
mouse	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
9707-9711	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
AngeL	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Jun-B	NULL
differs	NULL
in	NULL
its	NULL
biological	NULL
properties	NULL
from	NULL
and	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
,	NULL
c-jun	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
,	NULL
979-986	NULL
.	NULL

Chuvpilo	NULL
,	NULL
S.	NULL
,	NULL
Schomberg	NULL
,	NULL
C.	NULL
,	NULL
Gerwig.R	NULL
.	NULL

,	NULL
Heinfling	NULL
,	NULL
A.	NULL
,	NULL
Reeves	NULL
,	NULL
R.	NULL
,	NULL
Grummt	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Serfling	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Multiple	NULL
closely-linked	NULL
NFAT/	NULL
octamer	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
part	NULL
of	NULL
the	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
21	NULL
,	NULL
5694-5704	NULL
.	NULL

Constant	NULL
,	NULL
S.L	NULL
.	NULL

and	NULL
Bottomly	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Induction	NULL
of	NULL
Th1	NULL
and	NULL
Th2	NULL
CD4+	NULL
T	NULL
cell	NULL
responses	NULL
:	NULL
the	NULL
alternative	NULL
approaches	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
297-322	NULL
.	NULL

Davis	NULL
,	NULL
R.J	NULL
.	NULL

and	NULL
Czech	NULL
,	NULL
M.P	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Tumor-promoting	NULL
phorbol	NULL
diesters	NULL
cause	NULL
the	NULL
phosphorylation	NULL
of	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptors	NULL
in	NULL
normal	NULL
human	NULL
fibroblasts	NULL
at	NULL
threonine-654	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
82	NULL
,	NULL
1974-1978	NULL
.	NULL

Davydov	NULL
,	NULL
LV	NULL
.	NULL

,	NULL
Krammer	NULL
,	NULL
PH	NULL
.	NULL

and	NULL
Li-Weber	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nuclear	NULL
factor-IL6	NULL
activates	NULL
the	NULL
human	NULL
IL-4	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
155	NULL
,	NULL
5273-5279	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Wu	NULL
,	NULL
L.-H.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
Su	NULL
,	NULL
B.	NULL
,	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
J.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
JNK1	NULL
:	NULL
A	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
JunB	NULL
regulates	NULL
Th2	NULL
differentiation	NULL
Ha-Ras	NULL
that	NULL
inds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
,	NULL
76	NULL
,	NULL
1025-1037	NULL
.	NULL

Dickens	NULL
,	NULL
M.	NULL
,	NULL
Rogers	NULL
,	NULL
J.	NULL
,	NULL
Cavanagh	NULL
,	NULL
J.	NULL
,	NULL
Raitano	NULL
,	NULL
A.	NULL
,	NULL
Xia	NULL
,	NULL
Z.	NULL
,	NULL
Halpem	NULL
,	NULL
J.	NULL
,	NULL
Greenberg	NULL
,	NULL
M.	NULL
,	NULL
Sawyers	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
RJ	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
A	NULL
cytoplasmic	NULL
inhibitor	NULL
of	NULL
the	NULL
JNK	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Science	NULL
,	NULL
277	NULL
,	NULL
693-696	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Dérijard	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
R.J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Transcription	NULL
factor	NULL
ATF2	NULL
regulation	NULL
by	NULL
the	NULL
JNK	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Science	NULL
,	NULL
267	NULL
,	NULL
389-393	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
_	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
-	NULL
Whitmarsh	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
-	NULL
Cavanagh	NULL
,	NULL
J.	NULL
,	NULL
-	NULL
Sluss	NULL
,	NULL
HK	NULL
.	NULL

,	NULL
Dérijard	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
R.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Selective	NULL
interaction	NULL
of	NULL
JNK	NULL
protein	NULL
kinase	NULL
isoforms	NULL
with	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
2760-2770	NULL
.	NULL

Ho	NULL
,	NULL
ILC	NULL
.	NULL

,	NULL
Hodge	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Rooney	NULL
,	NULL
J.W	NULL
.	NULL

and	NULL
Glimcher	NULL
,	NULL
L.H	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
The	NULL
proto-oncogene	NULL
c-maf	NULL
is	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
interleukin-4	NULL
.	NULL

Cell	NULL
,	NULL
85	NULL
,	NULL
973-983	NULL
.	NULL

Ho	NULL
,	NULL
S.N	NULL
.	NULL

,	NULL
Hunt	NULL
,	NULL
H.D	NULL
.	NULL

,	NULL
Horton	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Pullen	NULL
,	NULL
J.K	NULL
.	NULL

and	NULL
Pease	NULL
,	NULL
L.R	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Site-directed	NULL
mutagenesis	NULL
by	NULL
overlap	NULL
extension	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Gene	NULL
,	NULL
77	NULL
,	NULL
51-59	NULL
.	NULL

Hogan	NULL
,	NULL
B.	NULL
,	NULL
Costantini	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Elizabeth	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Manipulating	NULL
the	NULL
Mouse	NULL
Embryo	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

Hsich	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Heimberger	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Gold	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
O'Garra	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Differential	NULL
regulation	NULL
of	NULL
T	NULL
helper	NULL
phenotype	NULL
development	NULL
by	NULL
interleukins	NULL
4	NULL
and	NULL
10	NULL
in	NULL
an	NULL
B	NULL
T-cell-receptor	NULL
transgenic	NULL
system	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
,	NULL
6065-6069	NULL
.	NULL

Hsich	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Macatonia	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Tripp	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Wolf	NULL
,	NULL
S.F	NULL
,	NULL
O'Garra	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Development	NULL
of	NULL
TH1	NULL
CD4+	NULL
T	NULL
cells	NULL
through	NULL
IL-12	NULL
produced	NULL
by	NULL
Listeria-induced	NULL
macrophages	NULL
.	NULL

Science	NULL
,	NULL
260	NULL
,	NULL
547-549	NULL
.	NULL

Tp	NULL
,	NULL
Y.T	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
R.J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Signal	NULL
transduction	NULL
by	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
-from	NULL
inflammation	NULL
to	NULL
development	NULL
.	NULL

Curr	NULL
Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
205-219	NULL
.	NULL

Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
Hibi	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
c-Jun	NULL
can	NULL
recruit	NULL
JNK	NULL
to	NULL
phosphorylate	NULL
dimerization	NULL
partners	NULL
via	NULL
specific	NULL
docking	NULL
interactions	NULL
.	NULL

Cell	NULL
,	NULL
87	NULL
,	NULL
929-939	NULL
.	NULL

Kamogawa	NULL
,	NULL
Y.	NULL
,	NULL
Minasi	NULL
,	NULL
L	NULL
.	NULL

A.	NULL
,	NULL
Carding	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Bottomly	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Flavell	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
The	NULL
relationship	NULL
of	NULL
IL-4-	NULL
and	NULL
IFN	NULL
y-producing	NULL
T	NULL
cells	NULL
studied	NULL
by	NULL
lineage	NULL
ablation	NULL
of	NULL
IL-4-producing	NULL
cells	NULL
.	NULL

Cell	NULL
,	NULL
75	NULL
,	NULL
985-995	NULL
.	NULL

Kerppola	NULL
,	NULL
T.K	NULL
.	NULL

and	NULL
Curran	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Maf	NULL
and	NULL
Nrl	NULL
can	NULL
bind	NULL
to	NULL
AP-1	NULL
sites	NULL
and	NULL
form	NULL
heterodimers	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
,	NULL
675-684	NULL
.	NULL

Killeen	NULL
,	NULL
N.	NULL
,	NULL
Sawada	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Littman	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Regulated	NULL
expression	NULL
of	NULL
human	NULL
CD4	NULL
rescues	NULL
helper	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
mice	NULL
lacking	NULL
expression	NULL
of	NULL
endogenous	NULL
CD4	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
1547-1553	NULL
.	NULL

Li-Weber	NULL
,	NULL
M.	NULL
,	NULL
Eder	NULL
,	NULL
A.	NULL
,	NULL
Krafft-Czepa	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Krammer	NULL
,	NULL
P.H	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
T	NULL
cell-specific	NULL
negative	NULL
regulation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
cytokine	NULL
IL-4	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
148	NULL
,	NULL
1913-1918	NULL
.	NULL

Manetti	NULL
,	NULL
R.	NULL
,	NULL
-	NULL
Parronchi	NULL
,	NULL
P.	NULL
,	NULL
Giudizi	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Piccinni	NULL
,	NULL
M.P	NULL
.	NULL

,	NULL
Maggi	NULL
,	NULL
E.	NULL
,	NULL
Trinchieri	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Romagnani	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Natural	NULL
killer	NULL
cell	NULL
stimulatory	NULL
factor	NULL
(	NULL
interleukin	NULL
12	NULL
[	NULL
IL-12	NULL
]	NULL
)	NULL
induces	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
-specific	NULL
immune	NULL
responses	NULL
and	NULL
inhibits	NULL
the	NULL
development	NULL
of	NULL
IL-4-producing	NULL
Th	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
177	NULL
,	NULL
1199-1204	NULL
.	NULL

Mosmann	NULL
,	NULL
T.R	NULL
.	NULL

,	NULL
-	NULL
Cherwinski	NULL
,	NULL
H.	NULL
,	NULL
Bond	NULL
,	NULL
M.W	NULL
.	NULL

,	NULL
-	NULL
Giedlin	NULL
,	NULL
M.A	NULL
.	NULL

-	NULL
and	NULL
Coffman	NULL
,	NULL
R.L	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Two	NULL
types	NULL
of	NULL
murine	NULL
helper	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

I	NULL
.	NULL

Definition	NULL
according	NULL
to	NULL
profiles	NULL
of	NULL
lymphokine	NULL
activities	NULL
and	NULL
secreted	NULL
proteins	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
136	NULL
,	NULL
2348-2357	NULL
.	NULL

Paul	NULL
,	NULL
W.E	NULL
.	NULL

and	NULL
Seder	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Lymphocyte	NULL
responses	NULL
and	NULL
cytokines	NULL
.	NULL

Cell	NULL
,	NULL
76	NULL
,	NULL
241-251	NULL
.	NULL

Rana	NULL
,	NULL
A.	NULL
,	NULL
Gallo	NULL
,	NULL
K.	NULL
,	NULL
Godowski	NULL
,	NULL
P.	NULL
,	NULL
Hirai	NULL
,	NULL
S.	NULL
,	NULL
Ohno	NULL
,	NULL
S.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
,	NULL
Kyriakis	NULL
,	NULL
J.M	NULL
.	NULL

and	NULL
Avruch	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
The	NULL
mixed	NULL
lineage	NULL
kinase	NULL
SPRK	NULL
phosphorylates	NULL
and	NULL
activates	NULL
the	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
activator	NULL
,	NULL
SEK-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
19025-19028	NULL
.	NULL

Reiner	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Zheng	NULL
,	NULL
S.	NULL
,	NULL
Corry	NULL
,	NULL
D.B	NULL
.	NULL

and	NULL
-	NULL
Locksley	NULL
,	NULL
R.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Constructing	NULL
polycompetitor	NULL
cDNAs	NULL
for	NULL
quantitative	NULL
PCR	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
,	NULL
175	NULL
,	NULL
275	NULL
.	NULL

Rincéon	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Flavell	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Transcription	NULL
mediated	NULL
by	NULL
NFAT	NULL
is	NULL
highly	NULL
inducible	NULL
in	NULL
effector	NULL
CD4+	NULL
T	NULL
helper	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Th1	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
,	NULL
1522-1534	NULL
.	NULL

Rincéon	NULL
,	NULL
.M	NULL
.	NULL

,	NULL
Dérijard	NULL
,	NULL
B.	NULL
,	NULL
Chow	NULL
,	NULL
C.	NULL
,	NULL
Davis	NULL
,	NULL
R.J	NULL
.	NULL

and	NULL
FlavelLR.A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Reprogramming	NULL
the	NULL
signalling	NULL
requirement	NULL
for	NULL
AP-1	NULL
(	NULL
activator	NULL
protein-1	NULL
)	NULL
activation	NULL
during	NULL
differentiation	NULL
of	NULL
precusor	NULL
CD4	NULL
T	NULL
cells	NULL
into	NULL
effector	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Genes	NULL
Funct	NULL
.	NULL

,	NULL
1	NULL
,	NULL
51-68	NULL
.	NULL

Robinson	NULL
,	NULL
M.J	NULL
.	NULL

and	NULL
Cobb	NULL
,	NULL
(	NULL
1997	NULL
)	NULL
Mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
180-186	NULL
.	NULL

Romagnani	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
The	NULL
Th1/Th2	NULL
paradigm	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
18	NULL
,	NULL
263-266	NULL
.	NULL

431	NULL
B.Li	NULL
et	NULL
al	NULL
.	NULL

Rooney	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
Hodge	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
McCaffrey	NULL
,	NULL
P.G	NULL
.	NULL

,	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Glimcher	NULL
,	NULL
L.H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
A	NULL
common	NULL
factor	NULL
regulates	NULL
both	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
625-633	NULL
.	NULL

Rooney	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
Hoey	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Glimcher	NULL
,	NULL
LH	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
,	NULL
2	NULL
,	NULL
473-483	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.M	NULL
.	NULL

and	NULL
Shaffner	NULL
,	NULL
W	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini'-extracts	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
17	NULL
,	NULL
6419	NULL
.	NULL

Schutte	NULL
,	NULL
J.	NULL
,	NULL
Viallet	NULL
,	NULL
J.	NULL
,	NULL
Nau	NULL
,	NULL
M.	NULL
,	NULL
Segal	NULL
,	NULL
S.	NULL
,	NULL
Fedorko	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Minna	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
jun-B	NULL
inhibits	NULL
and	NULL
c-fos	NULL
stimulates	NULL
the	NULL
transforming	NULL
and	NULL
trans-activating	NULL
activities	NULL
of	NULL
c-jun	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
,	NULL
987-997	NULL
.	NULL

Seder	NULL
,	NULL
R.A.	NULL
,	NULL
Paul	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
Davis	NULL
,	NULL
and	NULL
Fazekas	NULL
de	NULL
St	NULL
Groth	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
The	NULL
presence	NULL
of	NULL
interleukin	NULL
4	NULL
during	NULL
in	NULL
vitro	NULL
priming	NULL
determines	NULL
the	NULL
lymphokine-producing	NULL
potential	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
from	NULL
T	NULL
cell	NULL
receptor	NULL
transgenic	NULL
mice	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
176	NULL
,	NULL
1091-1098	NULL
.	NULL

Seder	NULL
,	NULL
R.A.	NULL
,	NULL
Gazzinelli	NULL
,	NULL
R.	NULL
,	NULL
Sher	NULL
,	NULL
A.	NULL
and	NULL
Paul	NULL
,	NULL
W.E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Interleukin	NULL
12	NULL
acts	NULL
directly	NULL
on	NULL
CD4+	NULL
T	NULL
cells	NULL
to	NULL
enhance	NULL
priming	NULL
for	NULL
interferon	NULL
y	NULL
production	NULL
and	NULL
diminishes	NULL
interleukin	NULL
4	NULL
inhibition	NULL
of	NULL
such	NULL
priming	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
10188-10192	NULL
.	NULL

Smith	NULL
,	NULL
S.B	NULL
.	NULL

and	NULL
Johnson	NULL
,	NULL
K.S	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Single-step	NULL
purification	NULL
of	NULL
polypeptides	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
as	NULL
fusions	NULL
with	NULL
glutathione-S-transferase	NULL
.	NULL

Gene	NULL
,	NULL
67	NULL
,	NULL
31-40	NULL
.	NULL

Swain	NULL
,	NULL
S.L	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
IL4	NULL
dictates	NULL
T-cell	NULL
differentiation	NULL
.	NULL

Res	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
144	NULL
,	NULL
616-620	NULL
.	NULL

Szabo	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
-	NULL
Gold	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
Murphy	NULL
,	NULL
T.L	NULL
.	NULL

-	NULL
and	NULL
-	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Identification	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
roles	NULL
for	NULL
NF-Y	NULL
and	NULL
NF-ATc	NULL
[	NULL
published	NULL
erratum	NULL
appears	NULL
in	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

1993	NULL
,	NULL
13	NULL
,	NULL
5928	NULL
]	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
4793-4805	NULL
.	NULL

Tibbles	NULL
,	NULL
L.A.	NULL
,	NULL
Ing	NULL
,	NULL
YL	NULL
.	NULL

,	NULL
Kiefer	NULL
,	NULL
F.	NULL
,	NULL
Chan	NULL
,	NULL
J.	NULL
,	NULL
Iscove	NULL
,	NULL
N.	NULL
,	NULL
Woodgett	NULL
,	NULL
J.R	NULL
.	NULL

and	NULL
Lassam	NULL
,	NULL
N.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
MLK-3	NULL
activates	NULL
the	NULL
SAPK/JNK	NULL
and	NULL
p38/RK	NULL
pathways	NULL
via	NULL
SEK1	NULL
and	NULL
MKK3/6	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
7026-7035	NULL
.	NULL

Todd	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Grusby	NULL
,	NULL
M.J.	NULL
,	NULL
Lederer	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Lacy	NULL
,	NULL
E.	NULL
,	NULL
Lichtman	NULL
,	NULL
A.H	NULL
.	NULL

and	NULL
Glimcher	NULL
,	NULL
L.H	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Transcription	NULL
of	NULL
the	NULL
interleukin	NULL
4	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
multiple	NULL
promoter	NULL
elements	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
177	NULL
,	NULL
1663-1674	NULL
.	NULL

Tournier	NULL
,	NULL
C.	NULL
,	NULL
Whitmarsh	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Cavanagh	NULL
,	NULL
J.	NULL
,	NULL
Barreft	NULL
,	NULL
I	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
RJ	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
7	NULL
is	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
c-Jun	NULL
NH2-terminal	NULL
kinase	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
94	NULL
,	NULL
7337-7342	NULL
.	NULL

Tugores	NULL
,	NULL
A.	NULL
,	NULL
Alonso	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Sanchez-Madrid	NULL
,	NULL
F	NULL
.	NULL

and	NULL
de	NULL
Landazuri	NULL
,	NULL
M.O	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Human	NULL
T	NULL
cell	NULL
activation	NULL
through	NULL
the	NULL
activation-inducer	NULL
molecule/CD69	NULL
enhances	NULL
hthe	NULL
activity	NULL
of	NULL
transcripiton	NULL
factor	NULL
AP-1	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
148	NULL
,	NULL
2300-2306	NULL
.	NULL

Wenner	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Szabo	NULL
,	NULL
S.J	NULL
.	NULL

and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Identification	NULL
of	NULL
IL-4	NULL
promoter	NULL
elements	NULL
conferring	NULL
Th2-restricted	NULL
expression	NULL
during	NULL
T	NULL
helper	NULL
cell	NULL
subset	NULL
development	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
158	NULL
,	NULL
765-773	NULL
.	NULL

Whitmarsh	NULL
,	NULL
A.	NULL
and	NULL
Davis	NULL
,	NULL
R.J.	NULL
(	NULL
1996	NULL
)	NULL
Transcription	NULL
factor	NULL
APO1	NULL
regulation	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
74	NULL
,	NULL
589-607	NULL
.	NULL

Zheng	NULL
,	NULL
W.	NULL
and	NULL
Flavell	NULL
,	NULL
R.A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
The	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
,	NULL
89	NULL
,	NULL
587-596	NULL
.	NULL

Received	NULL
September	NULL
8	NULL
,	NULL
1998	NULL
;	NULL
revised	NULL
November	NULL
24	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
November	NULL
25	NULL
,	NULL
1998	NULL
432	NULL

